[
  {
    "text": "TODD GOLUB: So I\ncome at this actually originally from a pediatric\noncology perspective.",
    "start": "0",
    "end": "5660"
  },
  {
    "text": "So I'm going to start\nby giving examples of a couple of patients that\nI saw in the Jimmy Fund clinic",
    "start": "5660",
    "end": "14280"
  },
  {
    "text": "at the Dana-Farber\nthat were typical. So the first patient was\na nine-year-old girl who",
    "start": "14280",
    "end": "22650"
  },
  {
    "text": "presented to her\npediatrician with-- turn these off? ",
    "start": "22650",
    "end": "30170"
  },
  {
    "text": "With a fever and bruises.  She got a blood test and\nthen a bone marrow test",
    "start": "30170",
    "end": "37940"
  },
  {
    "text": "that revealed that her bone\nmarrow had been replaced by acute leukemia cells--",
    "start": "37940",
    "end": "44660"
  },
  {
    "text": "acute lymphoblastic\nleukemia cells, or ALL. And so she was enrolled on what\nwas a standard chemotherapy",
    "start": "44660",
    "end": "51470"
  },
  {
    "text": "protocol, which was nine\ndifferent drugs in rotation and combination.",
    "start": "51470",
    "end": "57500"
  },
  {
    "text": "She entered remission\nin three weeks and is still alive and well. And then, a few months later,\nthere is a second patient--",
    "start": "57500",
    "end": "63710"
  },
  {
    "text": "this kid happened to be a\nboy, about the same age-- same presentation,\nsame diagnosis--",
    "start": "63710",
    "end": "70939"
  },
  {
    "text": "acute lymphoblastic\nleukemia-- was enrolled on the same treatment protocol. So got the same drugs.",
    "start": "70940",
    "end": "77810"
  },
  {
    "text": "Same hospital settings. So it was as close to\na controlled experiment as one could do in a human being\nbecause, of course, response",
    "start": "77810",
    "end": "86840"
  },
  {
    "text": "to any kind of\ntherapeutic intervention is not only a measure\nof the treatment",
    "start": "86840",
    "end": "92630"
  },
  {
    "text": "itself but how it's delivered.\nso that was controlled, But this patient didn't\nrespond, unfortunately,",
    "start": "92630",
    "end": "100730"
  },
  {
    "text": "and died about six months later. So the overarching\nquestion, that I'm",
    "start": "100730",
    "end": "105830"
  },
  {
    "text": "sure you've been addressing\nin this course, also, is generally how to understand\nthis clinical variability",
    "start": "105830",
    "end": "112640"
  },
  {
    "text": "and to discern whether there's\na molecular underpinning to that variability.",
    "start": "112640",
    "end": "119640"
  },
  {
    "text": "So we're particularly\ninterested in this patient who responded particularly\nwell and so did",
    "start": "119640",
    "end": "126260"
  },
  {
    "text": "what is pretty\nstraightforward, which is to do a standard chromosome\nanalysis, karyotyping",
    "start": "126260",
    "end": "133790"
  },
  {
    "text": "experiment using some\nmolecular techniques known as fluorescence in\nsitu hybridization.",
    "start": "133790",
    "end": "139400"
  },
  {
    "text": "Details don't really\nmatter, except to say that, while it wasn't apparent at the\nroutine morphological analysis",
    "start": "139400",
    "end": "148550"
  },
  {
    "text": "of the chromosomes, if\nyou look molecularly, it was clear that there\nis a translocation between",
    "start": "148550",
    "end": "153830"
  },
  {
    "text": "chromosomes 12 and 21\nthat fused two genes--",
    "start": "153830",
    "end": "159410"
  },
  {
    "text": "actually two\ntranscription factors-- one called TEL, one called AML-- to make this tell\nAML1 translocation.",
    "start": "159410",
    "end": "166898"
  },
  {
    "text": "And it turned out that, while\nit hadn't been previously discovered, actually,\nthe majority",
    "start": "166898",
    "end": "172790"
  },
  {
    "text": "of known genetic abnormalities\nin childhood leukemia--",
    "start": "172790",
    "end": "178680"
  },
  {
    "text": "the lion's share\nof those actually have this translocation.",
    "start": "178680",
    "end": "183920"
  },
  {
    "text": "And of those patients\nin retrospective and now perspective analyzes, about\n90% of those patients survive.",
    "start": "183920",
    "end": "192440"
  },
  {
    "text": "It turned out that patient\nnumber two had a different translocation-- a\n922 translocation--",
    "start": "192440",
    "end": "198980"
  },
  {
    "text": "that fuses two\ngenes BCR and ABL-- that you've probably\ntalked about.",
    "start": "198980",
    "end": "204515"
  },
  {
    "text": "And it's known that\nthese patients, give them the same therapeutic regimen,\nonly have about 10% survival.",
    "start": "204515",
    "end": "211230"
  },
  {
    "text": "And so these are molecular tests\ndone at the time of diagnosis.",
    "start": "211230",
    "end": "216920"
  },
  {
    "text": "So what I think this really\nsets up-- which is now perhaps",
    "start": "216920",
    "end": "222260"
  },
  {
    "text": "generally accepted but\nwas really emerging at this time-- was\nthe notion that cancer is a genetic disease,\nit seems like,",
    "start": "222260",
    "end": "228380"
  },
  {
    "text": "and that the outcome clinical\noutcome is predictable based on molecular determinants\nat the time of diagnosis",
    "start": "228380",
    "end": "235490"
  },
  {
    "text": "as long as you know\nwhat to look for. Yeah. AUDIENCE: Was this\nbefore Gleevec? TODD GOLUB: This\nis before Gleevec.",
    "start": "235490",
    "end": "241568"
  },
  {
    "text": "Turns out that, even with\nGleevec, which targets BCR-ABL, in these patients, it's\nnot particularly effective.",
    "start": "241568",
    "end": "249080"
  },
  {
    "text": "AUDIENCE: What is\nthe one [INAUDIBLE]?? TODD GOLUB: Uncharacterized. [AUDIO OUT] balance\ntranslocations",
    "start": "249080",
    "end": "258989"
  },
  {
    "text": "that identify a single\noncogene at a breakpoint. So we started thinking\nabout alternative ways",
    "start": "258990",
    "end": "266040"
  },
  {
    "text": "to try to think about molecular\nclassification of cancers more generally. And this is just the\nobvious experiment--",
    "start": "266040",
    "end": "275670"
  },
  {
    "text": "two biological states. They could be clinical\nstates or biological states--",
    "start": "275670",
    "end": "280770"
  },
  {
    "text": "that you collect some kind\nof genomic information on, like microarray data, and\nthen have this pesky problem",
    "start": "280770",
    "end": "287700"
  },
  {
    "text": "of actually trying to\nfigure out how to interpret the patterns that emerge. And I'll say quite a bit about\nthat part because it's tough.",
    "start": "287700",
    "end": "295050"
  },
  {
    "text": " Have you talked about\nthe non-analytical",
    "start": "295050",
    "end": "302860"
  },
  {
    "text": "but these laboratory aspects\nof microarrays at all?",
    "start": "302860",
    "end": "311270"
  },
  {
    "text": "Let me just spend one\nslide talking about this. So all of the microarrays are\nbased on the basic principle",
    "start": "311270",
    "end": "318370"
  },
  {
    "text": "of somehow labeling mRNA or\nits derivatives from a cell",
    "start": "318370",
    "end": "325540"
  },
  {
    "text": "and hybridizing to probes\non some of a solid support, whether it's a microscope slide\na silica wafer or something.",
    "start": "325540",
    "end": "334480"
  },
  {
    "text": "They're cDNA arrays, and\nthey're oligonucleotide arrays. And you can either\nmake them yourself or you can buy\nthem commercially.",
    "start": "334480",
    "end": "342790"
  },
  {
    "text": "cDNAs generally take the form of\ntwo-color hybridizations, where",
    "start": "342790",
    "end": "348010"
  },
  {
    "text": "you simultaneously hybridize\na test sample and a reference",
    "start": "348010",
    "end": "355510"
  },
  {
    "text": "or a control, whereas the\noligonucleotide arrays generally use a single color.",
    "start": "355510",
    "end": "361840"
  },
  {
    "text": "This is completely and\nentirely a historical artifact of how these things\nwere developed.",
    "start": "361840",
    "end": "366880"
  },
  {
    "text": "There's nothing intrinsic\nabout cDNA arrays that makes them require\ntwo-color hybridization.",
    "start": "366880",
    "end": "375430"
  },
  {
    "text": "The only reason for using\ntwo-color hybridization is, if the quality\nof arrays is so bad",
    "start": "375430",
    "end": "381970"
  },
  {
    "text": "that you need an internal\ncontrol for every spot. Otherwise you can't\ninterpret the data. And such was the case for the\nearliest cDNA arrays, which",
    "start": "381970",
    "end": "389243"
  },
  {
    "text": "were the first ones to be made.  And I would venture to say\nthat two arrays, in general,",
    "start": "389243",
    "end": "398680"
  },
  {
    "text": "are going to become obsolete\nvery quickly, in favor of oligonucleotide arrays--\nprobably commercial ones.",
    "start": "398680",
    "end": "406240"
  },
  {
    "text": "The genome is finite. Once you have the genome\nrepresented and identified, probably not much advantage\nto making your own.",
    "start": "406240",
    "end": "412925"
  },
  {
    "text": "And most of the\narguments that say, oh, we can make them much cheaper\nmaking them ourselves are usually Enron-type accounting\npractices where you",
    "start": "412925",
    "end": "424750"
  },
  {
    "text": "don't-- well, we didn't count\nthe cost of all the people involved in making these things.",
    "start": "424750",
    "end": "430121"
  },
  {
    "text": "We didn't include the fact that\nwe spent three years trying to figure out how to do these\nand they didn't exactly work. When you really get right down\nto it, usually buying them",
    "start": "430122",
    "end": "436875"
  },
  {
    "text": "is cheaper, and\nthey're higher quality. We should also mention that\nthere are non-microarray based expression\nprofiling methods,",
    "start": "436875",
    "end": "445180"
  },
  {
    "text": "like serial analysis of\ngene expression or something called MPSS, that are\ntranscript-counting-based",
    "start": "445180",
    "end": "452620"
  },
  {
    "text": "methods, where you\nuse essentially, DNA, sequencing to enumerate\nthe precise number of copies",
    "start": "452620",
    "end": "461889"
  },
  {
    "text": "of a given transcript\nin a given cell. And the proponents\nof this method say--",
    "start": "461890",
    "end": "469560"
  },
  {
    "text": "and they're correct--\nthis is the only way to really know how many copies\nof a particular transcript",
    "start": "469560",
    "end": "475389"
  },
  {
    "text": "that are in a particular cell. I would say that's\nabsolutely true, but it's actually\nnot that interesting",
    "start": "475390",
    "end": "482050"
  },
  {
    "text": "because, for most\nbiological questions, it actually doesn't matter\nhow many absolute copies",
    "start": "482050",
    "end": "487300"
  },
  {
    "text": "of transcript there are. It's not that\nuseful information. What's useful is to have some\nkind of comparative experiment",
    "start": "487300",
    "end": "493930"
  },
  {
    "text": "that tells you there are more\nwith statistical significance-- more in this sample\nthan that sample.",
    "start": "493930",
    "end": "499090"
  },
  {
    "text": "And rarely do you want to know\nthat there are 682 copies,",
    "start": "499090",
    "end": "505360"
  },
  {
    "text": "but it is true. But I would say that the\nlow throughput and cost",
    "start": "505360",
    "end": "511060"
  },
  {
    "text": "of these counting\nbased methods greatly outweighs the\nbenefit that you get from this absolute\ncounting-based method.",
    "start": "511060",
    "end": "517210"
  },
  {
    "text": "Yes. AUDIENCE: If you have\nmore copies of [INAUDIBLE]",
    "start": "517210",
    "end": "522834"
  },
  {
    "text": "this is what we're talking\nabout with [INAUDIBLE],, with the same gene. They are copies of the gene?",
    "start": "522835",
    "end": "530560"
  },
  {
    "text": "TODD GOLUB: Well, copies of the\ntranscript, not of the gene.",
    "start": "530560",
    "end": "535640"
  },
  {
    "text": "So you could say-- we sequenced-- we identified\na million total transcripts",
    "start": "535640",
    "end": "541600"
  },
  {
    "text": "in a cell of which 684 came-- were transcripts from--\nencoded by gene X.",
    "start": "541600",
    "end": "552280"
  },
  {
    "text": "So that can be useful\nquantitative information,",
    "start": "552280",
    "end": "557440"
  },
  {
    "text": "but not so useful to-- these experiments are\nstill many thousands",
    "start": "557440",
    "end": "562500"
  },
  {
    "text": "of dollars per sample.  AUDIENCE: When it comes down to\na pharmaceutical company trying",
    "start": "562500",
    "end": "570040"
  },
  {
    "text": "to figure out the mechanism of\nthe disease and actually how to go in and develop target\ndrug [INAUDIBLE] that might",
    "start": "570040",
    "end": "577900"
  },
  {
    "text": "interfere-- I'm assuming that this\ntechnique would be useful.",
    "start": "577900",
    "end": "583899"
  },
  {
    "text": "For example, if you did one\nof the above two [INAUDIBLE]",
    "start": "583900",
    "end": "588940"
  },
  {
    "text": "and you don't know the\nquantitative number of the transcripts\nyou have present, you're just going\nto, qualitatively,",
    "start": "588940",
    "end": "594970"
  },
  {
    "text": "more or less compared to disease\nstate or not or [INAUDIBLE] people [INAUDIBLE].",
    "start": "594970",
    "end": "600910"
  },
  {
    "text": "TODD GOLUB: Yeah. AUDIENCE: If you know\na number, doesn't it",
    "start": "600910",
    "end": "607240"
  },
  {
    "text": "give you ability to make\nspeculative speculation about how those transits\nare being processed",
    "start": "607240",
    "end": "613510"
  },
  {
    "text": "and whether that's an important\nprocess and the technology",
    "start": "613510",
    "end": "620160"
  },
  {
    "text": "becomes easier [INAUDIBLE]? TODD GOLUB: I would say\nit doesn't, actually, because if you tell\nme-- if God tells me",
    "start": "620160",
    "end": "625199"
  },
  {
    "text": "that there are 684 copies\nof a given transcript, I don't know what that means.",
    "start": "625200",
    "end": "631650"
  },
  {
    "text": "I do know what it means that--\nif there are five times as much",
    "start": "631650",
    "end": "638880"
  },
  {
    "text": "of a given transcript in\na disease state compared to a normal state, I can at\nleast say that having one fifth",
    "start": "638880",
    "end": "644790"
  },
  {
    "text": "the number of transcripts\nisn't sufficient to give you the disease state, whereas, if\nyou just give me an absolute",
    "start": "644790",
    "end": "649980"
  },
  {
    "text": "number without a\ncomparative thing, I don't know what that means,\nAnd I'm not sure that saying,",
    "start": "649980",
    "end": "657570"
  },
  {
    "text": "there's 600 in this state\nand 3,000 in that state--",
    "start": "657570",
    "end": "662670"
  },
  {
    "text": "to me, that's not really\nmore useful information than knowing relative abundance.",
    "start": "662670",
    "end": "670080"
  },
  {
    "text": "AUDIENCE: So it's\nreally a question of what the resolution is, in\nterms of common [INAUDIBLE]..",
    "start": "670080",
    "end": "679260"
  },
  {
    "text": "When you get an exact number\nfrom the bottom [INAUDIBLE] up to the top get a sufficiently\nresolved difference between",
    "start": "679260",
    "end": "688710"
  },
  {
    "text": "samples that you can say-- TODD GOLUB: That's right. That's right. AUDIENCE: 104 through 500.",
    "start": "688710",
    "end": "695018"
  },
  {
    "text": "TODD GOLUB: That's right. And I would say, for most\nbiological and clinical applications, knowing\nthat the ratio is 1 to 5",
    "start": "695018",
    "end": "703380"
  },
  {
    "text": "gives you about 95% of the\ninformation that's useful, compared to saying,\nit's 500 versus 100.",
    "start": "703380",
    "end": "710625"
  },
  {
    "text": "You might be able to think\nof some special experiments where you really want\nto know the number. But usually, it doesn't help\nyou very much, in my opinion.",
    "start": "710625",
    "end": "721300"
  },
  {
    "text": " There are all sorts of\nsources of variability that we won't discuss.",
    "start": "721300",
    "end": "727630"
  },
  {
    "text": "Except, there's only\none that matters. And that's the biological\nand clinical variability that",
    "start": "727630",
    "end": "734893"
  },
  {
    "text": "goes into these experiments. There are a lot of\npeople that spend a lot of time hand-wringing over\nthese very technical things,",
    "start": "734893",
    "end": "742390"
  },
  {
    "text": "and none of them make\nany difference, really, as far as I can tell\nbecause they're overwhelmed by biological variability.",
    "start": "742390",
    "end": "749330"
  },
  {
    "text": "So making microarrays\nthat are somewhat more accurate or precise\nin their measurement",
    "start": "749330",
    "end": "757090"
  },
  {
    "text": "won't actually make that\nmuch of a dent in the problem because that variability\nis exceeded so tremendously",
    "start": "757090",
    "end": "764830"
  },
  {
    "text": "by biological variability. That's all I'll say about that. So let me give some\nexamples of applying this.",
    "start": "764830",
    "end": "771410"
  },
  {
    "text": "And I know you've discussed\nthese general methods before, but that's OK.",
    "start": "771410",
    "end": "778120"
  },
  {
    "text": "So here's an\nexperiment where we are interested in the differentiable\nclinical outcome of children",
    "start": "778120",
    "end": "786220"
  },
  {
    "text": "with a brain tumor\ncalled medulloblastoma.",
    "start": "786220",
    "end": "791350"
  },
  {
    "text": "Have you discussed this\nparticular example? AUDIENCE: [INAUDIBLE]\nbut not this one. TODD GOLUB: OK. So we had 60 pre-treatment\nbiopsies of patients",
    "start": "791350",
    "end": "801310"
  },
  {
    "text": "with this brain tumor. Tumors were biopsied. And we knew the long-term\nclinical outcome of these patients-- whether\nthey survived from their disease",
    "start": "801310",
    "end": "810160"
  },
  {
    "text": "or they died despite therapy. They had the tumors removed and\nwere treated with chemotherapy",
    "start": "810160",
    "end": "816910"
  },
  {
    "text": "and radiation. And we knew that\nsome of the patients survived and some\nof them did not. And based on that, we\nsaid, well, perhaps there",
    "start": "816910",
    "end": "823540"
  },
  {
    "text": "are two classes-- subclasses of the disease. So we clustered the data.",
    "start": "823540",
    "end": "831339"
  },
  {
    "text": "This was across, I think,\n6,800 genes on a microarray. So each dot represents a\ndifferent patient sample.",
    "start": "831340",
    "end": "837430"
  },
  {
    "text": "We said, well, if there are\ntwo classes, let's cluster into two groups because we\nhave a clinical suspicion there",
    "start": "837430",
    "end": "846040"
  },
  {
    "text": "are two classes. And of course, if you ask\nthe algorithm to cluster",
    "start": "846040",
    "end": "851572"
  },
  {
    "text": "into two groups,\nin this case, it's something called a\nself-organizing map. But it doesn't matter. You could take the two major\nbranches on a dendrogram",
    "start": "851572",
    "end": "859260"
  },
  {
    "text": "from a hierarchical\nclustering dendrogram. Whatever. You get the same thing. You get two classes. And the patients are shown\nthere-- about equally",
    "start": "859260",
    "end": "866860"
  },
  {
    "text": "distributed. And now, if we fill in the\nlabels of the patients-- that is, whether\ntheir survivors--",
    "start": "866860",
    "end": "872259"
  },
  {
    "text": "turned out to be survivors\nor not survivors-- you get this picture, where-- ",
    "start": "872260",
    "end": "879970"
  },
  {
    "text": "you don't need a\nstatistician to tell you that there's no correlation\nbetween this class structure",
    "start": "879970",
    "end": "886060"
  },
  {
    "text": "and survival. So what do you take? What do you think\nof this experiment?",
    "start": "886060",
    "end": "892464"
  },
  {
    "text": "AUDIENCE: What do you\nguys think of this? TODD GOLUB: What\ncan you conclude?",
    "start": "892465",
    "end": "898700"
  },
  {
    "text": "AUDIENCE: What do\nyou do with this? How are you going\nto rescue this? Are you saying [INAUDIBLE]\nwas [INAUDIBLE] signature that [INAUDIBLE] survival? What do you say?",
    "start": "898700",
    "end": "905483"
  },
  {
    "text": "AUDIENCE: There's a\ndifference, but it may not be related to [INAUDIBLE]. AUDIENCE: But maybe there\nwas [INAUDIBLE] would",
    "start": "905483",
    "end": "912380"
  },
  {
    "text": "work somewhere else. [INAUDIBLE] TODD GOLUB: Right. I think you're both hitting\non the relevant point",
    "start": "912380",
    "end": "921089"
  },
  {
    "text": "here, which is that the\nunsupervised learning",
    "start": "921090",
    "end": "927160"
  },
  {
    "text": "clustering algorithm\nfound some structure-- dominant structure that\nmade these two classes. They just don't happen\nto have anything",
    "start": "927160",
    "end": "933430"
  },
  {
    "text": "to do with the question that\nwe're interested in, which was one of survival.",
    "start": "933430",
    "end": "939740"
  },
  {
    "text": "And so that gets back\nto this basic notion of two general approaches\nto data analysis, which",
    "start": "939740",
    "end": "948130"
  },
  {
    "text": "you've probably discussed but\nI think often gets confused.",
    "start": "948130",
    "end": "954050"
  },
  {
    "text": "So unsupervised\nlearning-- which is not exactly synonymous\nwith clustering, but it's a reasonable\nfirst approximation,",
    "start": "954050",
    "end": "960730"
  },
  {
    "text": "or supervised learning\nclassification. So here, you're interested in\nfinding a dominant structure",
    "start": "960730",
    "end": "969070"
  },
  {
    "text": "defined only by the\nintrinsic gene expression patterns in a given data\nset, irrespective of anything",
    "start": "969070",
    "end": "975220"
  },
  {
    "text": "you happen to know\nabout the samples, such as their clinical outcome. Here, you're saying, whatever.",
    "start": "975220",
    "end": "982060"
  },
  {
    "text": "Maybe there's some other\ninteresting biological structure. But I'm not interested\nin that right now. I want to know whether there's\na gene expression pattern that's",
    "start": "982060",
    "end": "989125"
  },
  {
    "text": "correlated with the\nthing I care about in this particular\nexample outcome.",
    "start": "989125",
    "end": "995690"
  },
  {
    "text": "So we take the same data set--\nthe same matrix of data samples by gene expression values and\nnow apply supervised learning",
    "start": "995690",
    "end": "1008259"
  },
  {
    "text": "approaches. This happens to be a K\nnearest neighbor classifier. Again, it doesn't make any\ndifference what you use here.",
    "start": "1008260",
    "end": "1015480"
  },
  {
    "text": "And this happens to be\nan eight-gene model. ",
    "start": "1015480",
    "end": "1022660"
  },
  {
    "text": "You classify the samples using\na leave-one-out cross-validation",
    "start": "1022660",
    "end": "1028140"
  },
  {
    "text": "approach so that you don't-- you attempt not to\noverfit the data--",
    "start": "1028140",
    "end": "1033510"
  },
  {
    "text": "the model to the\ninitial training set. And then you ask, well, , of the\ntwo classes that are predicted",
    "start": "1033510",
    "end": "1040859"
  },
  {
    "text": "how do those patients\nactually fare? And here is a survival\nplot in terms of months--",
    "start": "1040859",
    "end": "1046349"
  },
  {
    "text": "months of survival\nfor those patients who are predicted to\nbe alive versus those that are predicted to be dead.",
    "start": "1046349",
    "end": "1051617"
  },
  {
    "text": "So what do you think about this? ",
    "start": "1051617",
    "end": "1058490"
  },
  {
    "text": "AUDIENCE: This? So we'll pick those genes? TODD GOLUB: Is this significant? ",
    "start": "1058490",
    "end": "1068090"
  },
  {
    "text": "So if you look in a\nbasic biostatistics",
    "start": "1068090",
    "end": "1073130"
  },
  {
    "text": "textbook about how to calculate\nstatistical significance of a Kaplan-Meier survival\ncurve such as this is,",
    "start": "1073130",
    "end": "1079910"
  },
  {
    "text": "they'll tell you to\ndo the log rank test. And if you did that,\nyou would get a p-value",
    "start": "1079910",
    "end": "1085460"
  },
  {
    "text": "that, if you've looked\nat a lot of these things, would match your intuition\nfor this degree of separation.",
    "start": "1085460",
    "end": "1094070"
  },
  {
    "text": "So it would look\nsomething like that. Is that reasonable? Well, that looks\nquite significant.",
    "start": "1094070",
    "end": "1100460"
  },
  {
    "text": "But you should ask, well,\nhow come this model is eight genes, for example?",
    "start": "1100460",
    "end": "1105590"
  },
  {
    "text": "How did you choose that number? Well, it's quite easy. We chose that because\nI worked the best.",
    "start": "1105590",
    "end": "1111049"
  },
  {
    "text": "It worked better than six,\nworked better than 10, or 50. So we had to pay some\npenalty for overfitting",
    "start": "1111050",
    "end": "1121880"
  },
  {
    "text": "a model, potentially, to\nthis particular data set.",
    "start": "1121880",
    "end": "1128040"
  },
  {
    "text": "So the ways that you\ncould then really test the statistical\nsignificance of this model",
    "start": "1128040",
    "end": "1133970"
  },
  {
    "text": "would be to apply it\nto another data set. That's the gold standard. But short of that,\na reasonable thing",
    "start": "1133970",
    "end": "1139940"
  },
  {
    "text": "to do to better approximate\nthe significance is to take into account\nthe fact that there",
    "start": "1139940",
    "end": "1148910"
  },
  {
    "text": "are a number of parameters of\nthis model that were optimized to fit this data set.",
    "start": "1148910",
    "end": "1154520"
  },
  {
    "text": "And you can do this by doing\na permutation test, where you don't scramble the gene\nexpression values themselves,",
    "start": "1154520",
    "end": "1162770"
  },
  {
    "text": "but you randomize the\nclass labels in terms of, are the patients\nalive or dead, and you",
    "start": "1162770",
    "end": "1170330"
  },
  {
    "text": "go through the same\nprocedure of attempting to build an optimal\nclassifier and including",
    "start": "1170330",
    "end": "1176960"
  },
  {
    "text": "choosing the number of-- optimal number of genes\nto ask, if you really try hard with these\nmachine learning methods,",
    "start": "1176960",
    "end": "1185539"
  },
  {
    "text": "how often can you make\na classifier that works as well as this one does?",
    "start": "1185540",
    "end": "1190620"
  },
  {
    "text": "And when we did that 1,000\ntimes, 9 times out of 1,000, we could do this well or better.",
    "start": "1190620",
    "end": "1197970"
  },
  {
    "text": "So we estimated the\nsignificance of this model here, which is still decent.",
    "start": "1197970",
    "end": "1203780"
  },
  {
    "text": "But you can see we took a hit of\na couple of orders of magnitude on this p-value.",
    "start": "1203780",
    "end": "1209130"
  },
  {
    "text": "So if you had a nominal\np-value of 0.05 or something, that result would entirely\nvanish when you appropriately",
    "start": "1209130",
    "end": "1217160"
  },
  {
    "text": "attempt to correct for such\nmultiple hypothesis testing. And this is independent of what\nparticular classifier you used.",
    "start": "1217160",
    "end": "1226460"
  },
  {
    "text": "So I would say, much of the\nliterature-- and everyone's figuring on how to do\nthis as we go along. But much of the literature\nand worries about failure",
    "start": "1226460",
    "end": "1235399"
  },
  {
    "text": "to reproduce an\ninitial model are due to the problem\nof overestimating",
    "start": "1235400",
    "end": "1242600"
  },
  {
    "text": "the significance of an\ninitial model because of these overfitting\ntypes of problems. ",
    "start": "1242600",
    "end": "1250190"
  },
  {
    "text": "So let me just make a\ncouple of general comments about supervised learning.",
    "start": "1250190",
    "end": "1258820"
  },
  {
    "text": "And some of them\nmay seem obvious, but turn out to be\nactually problematic. And this is one example.",
    "start": "1258820",
    "end": "1264590"
  },
  {
    "text": "So the first step-- establish the class labels of\nwhat you're trying to classify.",
    "start": "1264590",
    "end": "1271690"
  },
  {
    "text": "So in one of our\nfirst experiments where we were trying to classify\nthe two different basic types of acute leukemia--",
    "start": "1271690",
    "end": "1278350"
  },
  {
    "text": "acute lymphoblastic leukemia\nor acute myeloid leukemia-- the way you build\na classifier is",
    "start": "1278350",
    "end": "1284440"
  },
  {
    "text": "to choose examples of one class,\nexamples of another class, and then find gene\nexpression patterns that",
    "start": "1284440",
    "end": "1290800"
  },
  {
    "text": "are correlated with that. Well, who's to say that we\nhave these right, right?",
    "start": "1290800",
    "end": "1297250"
  },
  {
    "text": "What should you use as the\ngold standard for these things? It's not always\nobvious, particularly for the very things that\nwe want to build better",
    "start": "1297250",
    "end": "1304570"
  },
  {
    "text": "molecular classifiers for\nbecause the current clinical diagnostics are so poor.",
    "start": "1304570",
    "end": "1311270"
  },
  {
    "text": "It doesn't really feel\nlike a good gold standard to go back, rely on the clinical\nlabels as the gold standard.",
    "start": "1311270",
    "end": "1318620"
  },
  {
    "text": "And so this is, in general, a. Real problem for\nsurvival studies, if you force the question into\na simple two-class problem--",
    "start": "1318620",
    "end": "1326530"
  },
  {
    "text": "survivor or non-survivor-- well everyone's a non\nsurvivor at some point. So at what point do you declare\nthat a patient is a survivor",
    "start": "1326530",
    "end": "1335289"
  },
  {
    "text": "of their tumor, for example? That requires some judgment\ncall in terms of which bin to put the samples into.",
    "start": "1335290",
    "end": "1342940"
  },
  {
    "text": "And I would say that much of\nat least our effort and time has gone into trying to figure\nout how to get this right.",
    "start": "1342940",
    "end": "1350567"
  },
  {
    "text": "And there are some\napproaches that one could take to not have\nto be so rigid on how",
    "start": "1350567",
    "end": "1356320"
  },
  {
    "text": "you assign these labels,\nbut it's a challenge. ",
    "start": "1356320",
    "end": "1361940"
  },
  {
    "text": "So the second general step\nin making the classifier",
    "start": "1361940",
    "end": "1368559"
  },
  {
    "text": "is selecting the\nfeatures that you're going to feed into a model--",
    "start": "1368560",
    "end": "1374500"
  },
  {
    "text": "features in this\ncase being genes. The details don't matter--\ntheir whole long list of ways that you can rank genes.",
    "start": "1374500",
    "end": "1382480"
  },
  {
    "text": "This is a simple one that is\nbased on the mean expression level in the two classes and\ntheir standard deviation.",
    "start": "1382480",
    "end": "1390910"
  },
  {
    "text": "It's a relatively\nunsophisticated way to select genes because\nit assumes that there's",
    "start": "1390910",
    "end": "1396640"
  },
  {
    "text": "a uniform behavior of these\nmarker genes in the two classes, which, in many\ncases, is not at all the case.",
    "start": "1396640",
    "end": "1405890"
  },
  {
    "text": "There are many other\nmethods as well. And then I'm sure you talked\nabout these at length.",
    "start": "1405890",
    "end": "1411710"
  },
  {
    "text": "So I think maybe I'll skip this,\nthat you then take these things and classify.",
    "start": "1411710",
    "end": "1419430"
  },
  {
    "text": "So for unsupervised learning,\nthere are all these methods.",
    "start": "1419430",
    "end": "1424920"
  },
  {
    "text": "And I think they\nbasically don't matter-- that, either for clustering\nor supervised machine learning",
    "start": "1424920",
    "end": "1435450"
  },
  {
    "text": "methods, if you\nget a result that is obtainable with\nonly one magical--",
    "start": "1435450",
    "end": "1442830"
  },
  {
    "text": "one person's really\nspecial algorithm, I would worry deeply that\nthere is a problem with--",
    "start": "1442830",
    "end": "1451500"
  },
  {
    "text": "there's an information\nleak somehow or something's not\nright because, at least",
    "start": "1451500",
    "end": "1457620"
  },
  {
    "text": "in my experience, when\nthere's really biologically or clinically meaningful\nstructure to be found,",
    "start": "1457620",
    "end": "1463120"
  },
  {
    "text": "you can find it with a number\nof different approaches. And in fact, that's a\nreasonable sanity check",
    "start": "1463120",
    "end": "1469620"
  },
  {
    "text": "to make sure that you\ncan recover structure, whether you're using\nmachine learning",
    "start": "1469620",
    "end": "1475530"
  },
  {
    "text": "or unsupervised clustering\nalgorithms-- that you can recover it with\nmultiple different methods.",
    "start": "1475530",
    "end": "1482880"
  },
  {
    "text": "There are some examples to\nthat that can be interesting. But on the whole, I'm confident\nsaying it doesn't really",
    "start": "1482880",
    "end": "1491400"
  },
  {
    "text": "matter, and it's really the\ninput to these data sets that matters the most-- that\nis, are you really sampling",
    "start": "1491400",
    "end": "1497310"
  },
  {
    "text": "the diversity of, for\nexample, the disease process that you're studying\nwith the samples that are in your initial data set?",
    "start": "1497310",
    "end": "1503430"
  },
  {
    "text": " What's more challenging\nis, how do you",
    "start": "1503430",
    "end": "1510389"
  },
  {
    "text": "evaluate the output\nof these clusters in terms of their\nbiology, in terms",
    "start": "1510390",
    "end": "1515400"
  },
  {
    "text": "of really knowing how\nrobust the structure is, given any algorithm?",
    "start": "1515400",
    "end": "1521130"
  },
  {
    "text": "And then how do you\nactually know when you-- having seen a given\nstructure once,",
    "start": "1521130",
    "end": "1527730"
  },
  {
    "text": "how do you actually\napply it to another data set to know whether you\nsee it there as well? It's not obvious.",
    "start": "1527730",
    "end": "1532860"
  },
  {
    "start": "1532860",
    "end": "1537970"
  },
  {
    "text": "Any questions about\nthat general stuff? I wasn't going to say\nany more because I know you've covered it.",
    "start": "1537970",
    "end": "1545092"
  },
  {
    "text": "Let me give a couple\nother examples of applying these principles\nto some data sets.",
    "start": "1545092",
    "end": "1551233"
  },
  {
    "text": "Did you talk about this one? AUDIENCE: No. TODD GOLUB: OK, so here-- again, focusing on\nchildhood leukemia--",
    "start": "1551233",
    "end": "1557799"
  },
  {
    "text": "most kids with childhood\nALL respond to chemotherapy.",
    "start": "1557800",
    "end": "1563650"
  },
  {
    "text": "I told you about this\nsubgroup of BCR-ABL patients that does not. Another group that\ndoes not respond well",
    "start": "1563650",
    "end": "1571480"
  },
  {
    "text": "are infants less\nthan a year of age, who generally don't respond.",
    "start": "1571480",
    "end": "1577180"
  },
  {
    "text": "It turns out that\nmost of those patients have translocations\ninto a gene called MLL. ",
    "start": "1577180",
    "end": "1584530"
  },
  {
    "text": "But it's clinically of interest\nbecause these patients don't respond to conventional\nchemotherapy,",
    "start": "1584530",
    "end": "1589720"
  },
  {
    "text": "and this just shows\nyou that, using standard clinical criteria,\nthey're hard to distinguish.",
    "start": "1589720",
    "end": "1595179"
  },
  {
    "text": "So what if we take\nconventional ALL samples, these infant MLL rearranged\nleukemias, and some AML--",
    "start": "1595180",
    "end": "1604090"
  },
  {
    "text": "the myeloid leukemias and we\napply an unsupervised learning",
    "start": "1604090",
    "end": "1609850"
  },
  {
    "text": "approach? This happens to be principal\ncomponent analysis, but could be your favorite\nclustering algorithm.",
    "start": "1609850",
    "end": "1616720"
  },
  {
    "text": " What do you see here?",
    "start": "1616720",
    "end": "1621809"
  },
  {
    "text": "AUDIENCE: What do you see?  AUDIENCE: Three\ndifferent classes.",
    "start": "1621810",
    "end": "1629130"
  },
  {
    "text": "TODD GOLUB: Three\ndifferent classes. Why do you say that? ",
    "start": "1629130",
    "end": "1636810"
  },
  {
    "text": "AUDIENCE: Jose, speak up. AUDIENCE: I mean, you're\nmaximizing the separation",
    "start": "1636810",
    "end": "1642710"
  },
  {
    "text": "so you see some separation--\nsome MLL [INAUDIBLE].. TODD GOLUB: OK, so right here. So, yes, you see three\nclasses, but only",
    "start": "1642710",
    "end": "1650450"
  },
  {
    "text": "if you have the\ncolors filled in. So if you imagine this is\njust a group of leukemias,",
    "start": "1650450",
    "end": "1658549"
  },
  {
    "text": "you might get the sense that\nthere was something going on over here.",
    "start": "1658550",
    "end": "1664380"
  },
  {
    "text": "But if you imagine\nthese are all black, it's not so obvious, maybe.",
    "start": "1664380",
    "end": "1670145"
  },
  {
    "text": "AUDIENCE: [INAUDIBLE]\nanalyzed or have been optimized [INAUDIBLE]? TODD GOLUB: No, this is\ncompletely unsupervised.",
    "start": "1670145",
    "end": "1675770"
  },
  {
    "text": "So that's the first point,\nis that these things often look clearer when you actually\nimpose knowledge on them.",
    "start": "1675770",
    "end": "1682220"
  },
  {
    "text": "Even though the structure here\nis done in an unsupervised way, you get the impression that\nit's really clean result",
    "start": "1682220",
    "end": "1689570"
  },
  {
    "text": "if you superimpose\nknowledge afterwards. That's the first thing. But let's say, yes,\nthey are three classes.",
    "start": "1689570",
    "end": "1695052"
  },
  {
    "text": "And I think you can\nappreciate that. One question was, well, maybe\nthese infants with the MLL--",
    "start": "1695052",
    "end": "1702350"
  },
  {
    "text": "rearranged genomes in green-- maybe they don't respond to\ntherapy because they're babies",
    "start": "1702350",
    "end": "1708230"
  },
  {
    "text": "and you know that this is\na metabolic post-metabolism problem. And their leukemias are the same\nas the conventional ALLs shown",
    "start": "1708230",
    "end": "1717150"
  },
  {
    "text": "in dark blue. This would argue that it's\nactually not the case, that they're fundamentally\ndifferent leukemia.",
    "start": "1717150",
    "end": "1723890"
  },
  {
    "text": "Is this helpful? ",
    "start": "1723890",
    "end": "1729880"
  },
  {
    "text": "So it's helpful, maybe,\nfrom a taxonomy perspective, but does it tell you what\nto do for these patients?",
    "start": "1729880",
    "end": "1737040"
  },
  {
    "text": "So what if you wanted to\ngain some biological insight into what was different\nabout these MLL green infant",
    "start": "1737040",
    "end": "1748950"
  },
  {
    "text": "leukemias? What might you do? You've got these data. You see that those patients\ndefine a different class.",
    "start": "1748950",
    "end": "1757800"
  },
  {
    "text": "What could you do? AUDIENCE: Any of\nyou have any idea? What would you do with this?",
    "start": "1757800",
    "end": "1764240"
  },
  {
    "text": "AUDIENCE: Inspect the component? Look for the things\nthat have higher weight?",
    "start": "1764240",
    "end": "1770100"
  },
  {
    "text": "Try to define biological\nfunction related to the [INAUDIBLE]? AUDIENCE: So the\ngenes whose weights",
    "start": "1770100",
    "end": "1776420"
  },
  {
    "text": "explain the most is separation. TODD GOLUB: That's right.",
    "start": "1776420",
    "end": "1781800"
  },
  {
    "text": " You could do that.",
    "start": "1781800",
    "end": "1787320"
  },
  {
    "text": "As it turns out,\nin this case, there are a lot of genes that actually\nhave relatively equal weight.",
    "start": "1787320",
    "end": "1794098"
  },
  {
    "text": "So you still have a large list. And the three\nprincipal components",
    "start": "1794098",
    "end": "1801120"
  },
  {
    "text": "don't perfectly\nseparate the classes. So you could go back\nand say, well now I believe that these\nMLL leukemias are",
    "start": "1801120",
    "end": "1808740"
  },
  {
    "text": "a distinct entity. That would be reasonable. That's a reasonable thing to do.",
    "start": "1808740",
    "end": "1814240"
  },
  {
    "text": "But the other way\nthat you could do is to say, well,\nnow this tells me that I believe that\nthese MLL leukemias are a distinct entity.",
    "start": "1814240",
    "end": "1819540"
  },
  {
    "text": "Now let's use supervised\nlearning types of methods to identify the genes that are\nmost correlated with the class",
    "start": "1819540",
    "end": "1828000"
  },
  {
    "text": "of interest-- for\nexample, high in the MLL class versus the others.",
    "start": "1828000",
    "end": "1834630"
  },
  {
    "text": "That would be a\nstraightforward thing to do. So you could rank the genes\naccording to that distinction.",
    "start": "1834630",
    "end": "1840640"
  },
  {
    "text": "So we did that and\ndid what I think-- yeah. AUDIENCE: [INAUDIBLE]\nIn the first case,",
    "start": "1840640",
    "end": "1849945"
  },
  {
    "text": "[INAUDIBLE] compare between\nthe different classifications--",
    "start": "1849945",
    "end": "1857389"
  },
  {
    "text": "the difference-- the\ndifferent genes-- [INAUDIBLE] expression\nor whatever? And the second case, you're\njust thinking comparing the one",
    "start": "1857390",
    "end": "1864330"
  },
  {
    "text": "classification? Is that correct? AUDIENCE: No. TODD GOLUB: No,\nI think it's more",
    "start": "1864330",
    "end": "1869910"
  },
  {
    "text": "that, if you didn't have these\ncolors to look at and you said, ah, there's some structure here.",
    "start": "1869910",
    "end": "1875660"
  },
  {
    "text": "I don't know what it is. What's the biological\nbasis of this structure? Looking at the weights\nof the genes that",
    "start": "1875660",
    "end": "1882600"
  },
  {
    "text": "are driving this distinction\nwould be a reasonable thing to do.",
    "start": "1882600",
    "end": "1887730"
  },
  {
    "text": "In this case, we had\na specific question. Are these leukemias\nunique, or are they",
    "start": "1887730",
    "end": "1892770"
  },
  {
    "text": "admixed with the others? Having determined\nthat they are unique, it's a little bit cleaner\nto say, all right,",
    "start": "1892770",
    "end": "1899310"
  },
  {
    "text": "let's use supervised methods to\nfind the genes that distinguish",
    "start": "1899310",
    "end": "1904920"
  },
  {
    "text": "one class from the other. Of course, if you had\nperfect separation, it would reduce to\nthe same experiment.",
    "start": "1904920",
    "end": "1912549"
  },
  {
    "text": "But because it's\nimperfect, there are some advantages to\nusing class labels here. I should mention also that-- you\nsee this blue guy here sitting",
    "start": "1912550",
    "end": "1921450"
  },
  {
    "text": "in a sea of green? So this is a patient that,\nbased on gene expression, one would predict to\nbe MLL rearranged.",
    "start": "1921450",
    "end": "1928230"
  },
  {
    "text": "But the clinical record for\nthis patient study was not. But when we went back and\nactually looked at this,",
    "start": "1928230",
    "end": "1935169"
  },
  {
    "text": "it turns out that\nthere was a missed translocation into the MLL gene\nthat you could recover by FISH.",
    "start": "1935170",
    "end": "1940380"
  },
  {
    "text": "So this is not a\npublic health menace--",
    "start": "1940380",
    "end": "1946650"
  },
  {
    "text": "diagnosing these\nleukemias properly. But there are examples of missed\ndiagnoses that I think can be--",
    "start": "1946650",
    "end": "1962220"
  },
  {
    "text": "I think looking at these\nmulti-parameter gene expression readouts can serve as a\nunifier, an integrator of lots",
    "start": "1962220",
    "end": "1969600"
  },
  {
    "text": "of upstream genetic activity. And so I think the power to\ndetect those upstream events is",
    "start": "1969600",
    "end": "1975330"
  },
  {
    "text": "going to be higher when you\nlook at some downstream pattern, such as an RNA\npattern, as opposed",
    "start": "1975330",
    "end": "1980940"
  },
  {
    "text": "to developing specific\ntests for each of the individual\ngenetic abnormalities",
    "start": "1980940",
    "end": "1986490"
  },
  {
    "text": "that could cause the same\nphenotype because, in the end, all you care about is knowing\nwhether the molecular program",
    "start": "1986490",
    "end": "1992309"
  },
  {
    "text": "has been activated. So you rank the genes\naccording to this distinction",
    "start": "1992310",
    "end": "1998550"
  },
  {
    "text": "and just start at\nthe top of the list-- here is a gene that was top of\nthe list of 12,600 or whatever",
    "start": "1998550",
    "end": "2007070"
  },
  {
    "text": "that we're on on the list. And any time a tyrosine\nkinase rears its head",
    "start": "2007070",
    "end": "2015950"
  },
  {
    "text": "in a cancer classification-- cancer biology experiment,\nyou pay attention to it,",
    "start": "2015950",
    "end": "2021080"
  },
  {
    "text": "particularly given\nthe Gleevec story. So what do you think about this? I tell you, oh, look at this.",
    "start": "2021080",
    "end": "2028220"
  },
  {
    "text": "The RNA level of a kinase-- so a receptor\ntyrosine kinase called",
    "start": "2028220",
    "end": "2033230"
  },
  {
    "text": "FLT3 is characteristically\nhigh in the MLLs,",
    "start": "2033230",
    "end": "2041179"
  },
  {
    "text": "compared to the others. What do you think of that,\nin terms of therapeutic-- potential therapeutic\nsignificance?",
    "start": "2041180",
    "end": "2050000"
  },
  {
    "text": "AUDIENCE: What would\nyou do with that? AUDIENCE: [INAUDIBLE].",
    "start": "2050000",
    "end": "2055117"
  },
  {
    "text": "Or maybe this\nalready popped out, but can't you check the\nlevels in the other two",
    "start": "2055117",
    "end": "2060158"
  },
  {
    "text": "classifications? AUDIENCE: Because these\n[INAUDIBLE] slower. TODD GOLUB: Right. So we define this list\nby virtue of the fact",
    "start": "2060159",
    "end": "2066770"
  },
  {
    "text": "that it's high in the MLLs\ncompared to the other two combined.",
    "start": "2066770",
    "end": "2072589"
  },
  {
    "text": "AUDIENCE: So how do we get\nthe therapeutic K out of this? AUDIENCE: For the\npatients patient are responsive [INAUDIBLE]",
    "start": "2072590",
    "end": "2080169"
  },
  {
    "text": " Are they classified as\nfar as the response,",
    "start": "2080170",
    "end": "2086489"
  },
  {
    "text": "the FLT3 inhibitor? TODD GOLUB: To a FLT3 inhibitor. AUDIENCE: Yeah. TODD GOLUB: So you want to treat\npatients with a FLT3 inhibitor?",
    "start": "2086489",
    "end": "2092879"
  },
  {
    "text": "Well, that's not an FDA-approved\ndrug, so you can't do that. ",
    "start": "2092880",
    "end": "2098817"
  },
  {
    "text": "AUDIENCE: OK, so\nwhat else do we have? ",
    "start": "2098817",
    "end": "2104692"
  },
  {
    "text": "AUDIENCE: [INAUDIBLE] ",
    "start": "2104693",
    "end": "2114339"
  },
  {
    "text": "TODD GOLUB: So there is.  The hypothesis would\nbe that MLL leukemia",
    "start": "2114340",
    "end": "2123589"
  },
  {
    "text": "cells are dependent on FLT3\nkinase activity for survival.",
    "start": "2123590",
    "end": "2129560"
  },
  {
    "text": "If that's not the case,\nthen you don't care.",
    "start": "2129560",
    "end": "2134600"
  },
  {
    "text": "Unless that's the case, the\noverexpression of this thing is totally irrelevant from\na therapeutic perspective.",
    "start": "2134600",
    "end": "2140660"
  },
  {
    "text": "So you could do that\ngenetically-- for example, using RNA interference to\nknock down the expression,",
    "start": "2140660",
    "end": "2147200"
  },
  {
    "text": "or you could do it\npharmacologically, if there was a compound in\ndevelopment-- not yet a drug--",
    "start": "2147200",
    "end": "2152329"
  },
  {
    "text": "but a compound in development\nthat inhibits kinase activity.",
    "start": "2152330",
    "end": "2158330"
  },
  {
    "text": "And so that's what\nthis experiment is. AUDIENCE: So [INAUDIBLE]",
    "start": "2158330",
    "end": "2164780"
  },
  {
    "text": " Doing RNA interference--\nis that something that you can just\ndo in a person?",
    "start": "2164780",
    "end": "2169790"
  },
  {
    "text": "TODD GOLUB: You can't do\nit in vivo in a person, but you can do it in\nhuman-derived cell lines.",
    "start": "2169790",
    "end": "2176930"
  },
  {
    "text": "AUDIENCE: So clinically, that\nwould not be [INAUDIBLE].. AUDIENCE: You could test\nthe hypothesis that you",
    "start": "2176930",
    "end": "2182840"
  },
  {
    "text": "want to go down that path. AUDIENCE: I see. TODD GOLUB: That's right. Now, you can make the\nargument that, well,",
    "start": "2182840",
    "end": "2189440"
  },
  {
    "text": "doing these things in\ncell lines in mice-- that's not real disease. And so I don't care what\nany of this stuff shows.",
    "start": "2189440",
    "end": "2196820"
  },
  {
    "text": "But still, if your hypothesis\nis that a given gene--",
    "start": "2196820",
    "end": "2202190"
  },
  {
    "text": "the overexpression of a\ngiven gene is important and you do the\nexperiments to ablate",
    "start": "2202190",
    "end": "2208010"
  },
  {
    "text": "the expression of that\ngene and nothing happens, that should deflate your\nenthusiasm a little bit.",
    "start": "2208010",
    "end": "2215280"
  },
  {
    "text": "So here's the\nexperiment, though. Here, now, taking\npatient-derived human cells",
    "start": "2215280",
    "end": "2220670"
  },
  {
    "text": "that have been engineered to\nexpress firefly luciferase genes so that they glow--",
    "start": "2220670",
    "end": "2227819"
  },
  {
    "text": "and you can monitor\nin vivo tumor burden. So here, mice that,\non week one, you",
    "start": "2227820",
    "end": "2233119"
  },
  {
    "text": "inject in the tail vein infant\nleukemia-derived tumor cells.",
    "start": "2233120",
    "end": "2240980"
  },
  {
    "text": "And you see, over 4\nweeks time, the amount of luciferase activity\nincreases as the cells grow",
    "start": "2240980",
    "end": "2249019"
  },
  {
    "text": "and the mice start\nto die around week 4. And here is a cohort of mice\nalso injected but treated",
    "start": "2249020",
    "end": "2258050"
  },
  {
    "text": "with a drug once a day by mouth\nthat functions as a FLT3 kinase",
    "start": "2258050",
    "end": "2265400"
  },
  {
    "text": "inhibitor. And you can see that the\ndevelopment of the leukemia is significantly\nabrogated, which,",
    "start": "2265400",
    "end": "2273680"
  },
  {
    "text": "at least to our\nfirst approximation, validates the hypothesis that\nFLT3 overexpression is not just",
    "start": "2273680",
    "end": "2280040"
  },
  {
    "text": "a diagnostic marker\nof this class, but it's actually a\npotential therapeutic target.",
    "start": "2280040",
    "end": "2285589"
  },
  {
    "text": "And so, based on this and\nsome other preclinical data, the clinical trial\nthat you wanted",
    "start": "2285590",
    "end": "2291140"
  },
  {
    "text": "to do with a FLT3\ninhibitor is being planned to treat patients.",
    "start": "2291140",
    "end": "2296630"
  },
  {
    "text": "Yeah. AUDIENCE: [INAUDIBLE] ",
    "start": "2296630",
    "end": "2301640"
  },
  {
    "text": "TODD GOLUB: So the cells are\ninfected with a retrovirus that contains the cDNA for the\nfirefly luciferase gene so",
    "start": "2301640",
    "end": "2313730"
  },
  {
    "text": "that, if you inject these mice\nwith the compound luciferin,",
    "start": "2313730",
    "end": "2320000"
  },
  {
    "text": "they will emit the same\nenzyme that fireflies do,",
    "start": "2320000",
    "end": "2326330"
  },
  {
    "text": "and they will glow. So usually, this is done\nin vitro in test tubes. But here, you introduce it\ninto the cells and the animal",
    "start": "2326330",
    "end": "2334580"
  },
  {
    "text": "so that you can monitor. What you used to\nhave to do would be to inject a whole bunch\nof mice, kill some of them",
    "start": "2334580",
    "end": "2342350"
  },
  {
    "text": "here, kill some of them\nhere, and then examine the bone marrows to evaluate\nthe progression of the disease.",
    "start": "2342350",
    "end": "2348870"
  },
  {
    "text": "What's nice here is that you\ncan follow a cohort of mice non-invasively. AUDIENCE: Let me ask a dumb\nquestion, because I've never",
    "start": "2348870",
    "end": "2354070"
  },
  {
    "text": "actually done this. When you actually\nlook at these mice, can you tell that\nthey're fluorescent?",
    "start": "2354070",
    "end": "2359450"
  },
  {
    "text": "TODD GOLUB: No. No. AUDIENCE: They don't\nactually look-- no. TODD GOLUB: No, you need to\nuse a special device that",
    "start": "2359450",
    "end": "2366290"
  },
  {
    "text": "can measure, I think, in\nthe near-infrared range. There are green\nfluorescent protein mice",
    "start": "2366290",
    "end": "2374000"
  },
  {
    "text": "that actually do glow. And you can tell\nthat they're green. ",
    "start": "2374000",
    "end": "2380869"
  },
  {
    "text": "AUDIENCE: The mice that\nwe use-- are they immune [INAUDIBLE],, which\nmeans you don't",
    "start": "2380870",
    "end": "2386480"
  },
  {
    "text": "have a massive immune response? TODD GOLUB: So you have to do\nthis in immunodeficient mice",
    "start": "2386480",
    "end": "2392029"
  },
  {
    "text": "so that they don't\nreject the human tumors. ",
    "start": "2392030",
    "end": "2398155"
  },
  {
    "text": "AUDIENCE: Does\nthat factor at all in your determination of\nthe degree of proposed--",
    "start": "2398155",
    "end": "2405580"
  },
  {
    "text": "the spread of the\ntumor cells and whatnot because they're just there?",
    "start": "2405580",
    "end": "2411410"
  },
  {
    "text": "The immune system can\ndirect attacks against-- so when you're considering\nthese experiments and saying,",
    "start": "2411410",
    "end": "2417780"
  },
  {
    "text": "OK, I see this spread\nacross the entire mouse and this level of [INAUDIBLE]\nhow do you factor that in?",
    "start": "2417780",
    "end": "2424233"
  },
  {
    "text": "TODD GOLUB: You don't. You factor that in by saying\nthat there are many things that",
    "start": "2424233",
    "end": "2429559"
  },
  {
    "text": "are occurring in these models\nthat don't recapitulate",
    "start": "2429560",
    "end": "2435260"
  },
  {
    "text": "what happens in the mouse. Most people don't get cancer\nby having intravenous injection",
    "start": "2435260",
    "end": "2440660"
  },
  {
    "text": "of a tumor into them. Most patients have\nan immune system.",
    "start": "2440660",
    "end": "2445819"
  },
  {
    "text": "So I think it's just one\nof the limitations that-- ",
    "start": "2445820",
    "end": "2451970"
  },
  {
    "text": "it would not be worth\nthe time and expense to have a drug\ndevelopment project",
    "start": "2451970",
    "end": "2457220"
  },
  {
    "text": "around every little\ninkling that comes out of a microarray experiment. So you need to do something,\neven though it's deficient",
    "start": "2457220",
    "end": "2464809"
  },
  {
    "text": "in many ways-- and you've\nhit on some of them-- to say, is this\ninteresting or is it not?",
    "start": "2464810",
    "end": "2471680"
  },
  {
    "text": "I think-- not yet\nat the point where one can do this\nentirely computationally and have any kind of confidence.",
    "start": "2471680",
    "end": "2479240"
  },
  {
    "text": "That being said, these\nso-called xenograft models, where you put a human\ntumor into a mouse model,",
    "start": "2479240",
    "end": "2488090"
  },
  {
    "text": "are not particularly\npredictive of efficacy",
    "start": "2488090",
    "end": "2493220"
  },
  {
    "text": "of a drug in the\nhuman clinical trial. But in the absence of\nanything better, it's still what most people do first.",
    "start": "2493220",
    "end": "2499730"
  },
  {
    "text": "AUDIENCE: [INAUDIBLE] more\nrobust, in other words, if there's no effect\non the xenografts, then you're really\na loser if you",
    "start": "2499730",
    "end": "2505340"
  },
  {
    "text": "go to the human [INAUDIBLE]? TODD GOLUB: No. If anything, it's the\nopposite, that, if you",
    "start": "2505340",
    "end": "2511490"
  },
  {
    "text": "show some activity\nin the xenografts, you often see activity. But failure to see activity--",
    "start": "2511490",
    "end": "2519150"
  },
  {
    "text": "failure to see\nactivity in xenografts is not particularly-- particularly for\nmolecularly targeted",
    "start": "2519150",
    "end": "2524540"
  },
  {
    "text": "therapies, where it may be\nthat you can show in the mouse that you've really\nshut down the pathway.",
    "start": "2524540",
    "end": "2531660"
  },
  {
    "text": "Let's say you've\ninhibited FLT3 completely. Drug companies are starting to\nuse graphs in that way to say,",
    "start": "2531660",
    "end": "2538970"
  },
  {
    "text": "all the mouse is is a test\ntube so that I can ask-- have I inhibited FLT3\nenzymatic activity?",
    "start": "2538970",
    "end": "2546860"
  },
  {
    "text": "Yes or no. If I have and I believe\nthat FLT3 is a good target,",
    "start": "2546860",
    "end": "2552470"
  },
  {
    "text": "I don't care whether the\ntumor's actually shrunk or not. I'm going to bring it\nforward to clinical trial.",
    "start": "2552470",
    "end": "2559107"
  },
  {
    "text": "But you need something\nto convince you that the target is\nreasonable, yeah. AUDIENCE: An\ninteresting [INAUDIBLE]..",
    "start": "2559107",
    "end": "2564410"
  },
  {
    "text": "So the small spots in the\n[INAUDIBLE] three mouses are--",
    "start": "2564410",
    "end": "2570905"
  },
  {
    "text": "the purple ones are\nthe xenographs, right? The purple spots\nare the xenographs. AUDIENCE: Are the tumors.",
    "start": "2570905",
    "end": "2577230"
  },
  {
    "text": "TODD GOLUB: Yeah. AUDIENCE: But that means\nthe spots are all very fixed in specific areas of the mouse.",
    "start": "2577230",
    "end": "2582776"
  },
  {
    "text": "TODD GOLUB: Yeah, I\nthink you see them there because the cells-- they're injected intravenously\nin the tail vein,",
    "start": "2582777",
    "end": "2590100"
  },
  {
    "text": "but they home to the\nbone marrow and you're seeing large bone marrow\ncavities, which is why you",
    "start": "2590100",
    "end": "2596010"
  },
  {
    "text": "see them over the flank there.  I think I'm going to skip this.",
    "start": "2596010",
    "end": "2602220"
  },
  {
    "start": "2602220",
    "end": "2612320"
  },
  {
    "text": "OK, did you talk about this? AUDIENCE: No. TODD GOLUB: Good. ",
    "start": "2612320",
    "end": "2618800"
  },
  {
    "text": "So when you do\nthese experiments, the data usually\npresent you with two--",
    "start": "2618800",
    "end": "2627290"
  },
  {
    "text": "you either have\none or two problems after you do all this\nappropriate correction",
    "start": "2627290",
    "end": "2632570"
  },
  {
    "text": "for multiple hypothesis\ntesting that I told you about. Despite having done\nthat, you still",
    "start": "2632570",
    "end": "2638060"
  },
  {
    "text": "have a list of genes\nthat's too impossibly long to bring biological\nunderstanding to,",
    "start": "2638060",
    "end": "2644030"
  },
  {
    "text": "or you've corrected\naway everything",
    "start": "2644030",
    "end": "2651048"
  },
  {
    "text": "and you have the impression\nthat there's actually nothing that is differentially\nexpressed in your two cases.",
    "start": "2651048",
    "end": "2658430"
  },
  {
    "text": "And so let me show some of\nthe more recent approaches to dealing with this because\nit's really substantially",
    "start": "2658430",
    "end": "2663770"
  },
  {
    "text": "changing our thinking\nabout how to do these kinds of experiments. So this is not a cancer example\nbut a diabetes experiment",
    "start": "2663770",
    "end": "2673009"
  },
  {
    "text": "where there were patients\nwho were either-- adult patients who either\nhad type 2 diabetes or they",
    "start": "2673010",
    "end": "2682700"
  },
  {
    "text": "were normal, as defined\nby having a normal glucose tolerance test.",
    "start": "2682700",
    "end": "2688760"
  },
  {
    "text": "And they underwent voluntary\nskeletal muscle biopsies under a euglycemic clamp.",
    "start": "2688760",
    "end": "2696589"
  },
  {
    "text": "18 of these patients,\n17 of these patients-- it's a simple two-class problem. Get the expression\ndata to identify",
    "start": "2696590",
    "end": "2703940"
  },
  {
    "text": "those genes that\nare differentially expressed in these two classes. Do the appropriate\npermutation testing",
    "start": "2703940",
    "end": "2710210"
  },
  {
    "text": "to make sure that you correct\nfor multiple hypothesis testing. And here's the result.\nNothing meets significance.",
    "start": "2710210",
    "end": "2719390"
  },
  {
    "text": "So out of the 20,000\ngenes on the array, even the top-ranked gene doesn't\nmeet statistical significance.",
    "start": "2719390",
    "end": "2728030"
  },
  {
    "text": "Possible that this is the case. But the question is,\nare there other ways",
    "start": "2728030",
    "end": "2734450"
  },
  {
    "text": "that you might go\nabout recovering a biological story here?",
    "start": "2734450",
    "end": "2740220"
  },
  {
    "text": "And so the way that Vamsi Mootha\nand graduate student, Arvind",
    "start": "2740220",
    "end": "2745400"
  },
  {
    "text": "Subramanian took to this was to\ndefine groups of genes or gene",
    "start": "2745400",
    "end": "2754609"
  },
  {
    "text": "sets whose activity as\na collection of genes",
    "start": "2754610",
    "end": "2760430"
  },
  {
    "text": "could be interrogated\nin these data sets. And we could have a\nrich discussion about,",
    "start": "2760430",
    "end": "2765920"
  },
  {
    "text": "how does one define\nsuch gene sets? You could do it based\non the literature. So ask Zach what genes are\nimportant in some pathway",
    "start": "2765920",
    "end": "2774260"
  },
  {
    "text": "that he knows something about. That could be a list. Or you could say, we\ndon't trust that about--",
    "start": "2774260",
    "end": "2781100"
  },
  {
    "text": "that'll bring Zach's bias. We're not interested in that\nor anyone else's intuition. Let's just experimentally\nderive lists of genes",
    "start": "2781100",
    "end": "2790250"
  },
  {
    "text": "by one way or the\nother-- perturb cells, get the gene expression change,\nand that makes a gene set.",
    "start": "2790250",
    "end": "2795800"
  },
  {
    "text": "And you can collect as many\nof these as you could stand. For these experiments, we\nmade 150 of these gene sets.",
    "start": "2795800",
    "end": "2804520"
  },
  {
    "text": "AUDIENCE: Before we go on,\n[INAUDIBLE] twice on the slide. TODD GOLUB: Oh, yeah.",
    "start": "2804520",
    "end": "2809740"
  },
  {
    "text": "AUDIENCE: So he's enriched one. TODD GOLUB: He's enriched. Yeah, he should be. ",
    "start": "2809740",
    "end": "2816849"
  },
  {
    "text": "So then how do you do this? So first thing you do is rank\nall the genes on the array--",
    "start": "2816850",
    "end": "2824109"
  },
  {
    "text": "1 through 20,000-- according\nto how well they're correlated with the distinction.",
    "start": "2824110",
    "end": "2829580"
  },
  {
    "text": "I already told\nyou this top one-- even that one doesn't meet\nsignificance as a single gene. And then you interrogate each\nof these gene sets and ask,",
    "start": "2829580",
    "end": "2838240"
  },
  {
    "text": "are they enriched? And so here would be an example\nof a hypothetical gene set,",
    "start": "2838240",
    "end": "2843440"
  },
  {
    "text": "so each gene in the gene set\nof a dozen genes or whatever, that is not enriched towards\nthe top of this rank-ordered set",
    "start": "2843440",
    "end": "2853990"
  },
  {
    "text": "list, whereas here is a\nhypothetical gene set. It's not perfect.",
    "start": "2853990",
    "end": "2860650"
  },
  {
    "text": "But it's non-randomly\ndistributed on this rank order list. It's enriched towards the top.",
    "start": "2860650",
    "end": "2865730"
  },
  {
    "text": "AUDIENCE: Do you see this\nas a similar operation to the following-- there's a bunch of proteins that\nthey would look at [INAUDIBLE]",
    "start": "2865730",
    "end": "2872680"
  },
  {
    "text": "giving microarray result at\ngene ontology, and they'd say, what classes of gene ontology\nare overrepresented given--",
    "start": "2872680",
    "end": "2884660"
  },
  {
    "text": "in this set of genes? TODD GOLUB: Yes. So you can define these gene\nsets based on a gene ontology",
    "start": "2884660",
    "end": "2892210"
  },
  {
    "text": "annotation. That's an example. The important part\nis to make sure that you appropriately correct\nfor testing all the gene sets.",
    "start": "2892210",
    "end": "2900890"
  },
  {
    "text": "So now, instead of 22,000\ngenes, we have 150 gene sets. But that you should\nthink of 150 hypotheses.",
    "start": "2900890",
    "end": "2909099"
  },
  {
    "text": "So you should do the same\npermutation type of testing",
    "start": "2909100",
    "end": "2915970"
  },
  {
    "text": "and say, if I randomize--\nin this case-- the diabetes versus\nnormal distinction, is my favorite gene ontology\nclass still enriched?",
    "start": "2915970",
    "end": "2923950"
  },
  {
    "text": "And that's what some of the\ncurrent approaches to that kind of annotation don't do.",
    "start": "2923950",
    "end": "2929180"
  },
  {
    "text": "And so you can codify\nthis in something called a Kolmogorov-Smirnov\nstatistic. It doesn't matter.",
    "start": "2929180",
    "end": "2934190"
  },
  {
    "text": "You can come up with\nan enrichment score for these things. And if you do that\nin this example you essentially get 1\ngene set which meets--",
    "start": "2934190",
    "end": "2944100"
  },
  {
    "text": "AUDIENCE: [INAUDIBLE]  TODD GOLUB: Which gets quite\nhigh statistical significance",
    "start": "2944100",
    "end": "2953520"
  },
  {
    "text": "for a set of genes. So how do you reconcile this?",
    "start": "2953520",
    "end": "2959010"
  },
  {
    "text": "How do you reconcile this\nthing and this thing? How could that be? AUDIENCE: That's my point.",
    "start": "2959010",
    "end": "2964570"
  },
  {
    "text": "I want to understand what you\njust were trying to explain. So the first thing-- you're\nsaying that you didn't pick up",
    "start": "2964570",
    "end": "2970900"
  },
  {
    "text": "any difference in\nthe expression-- AUDIENCE: On a\ngene-by-gene basis. TODD GOLUB: That's right. AUDIENCE: But then,\nwhen you group",
    "start": "2970900",
    "end": "2976510"
  },
  {
    "text": "a couple of them\ntogether, all of a sudden, there is a difference. TODD GOLUB: Right. So how could that be? AUDIENCE: How could that be?",
    "start": "2976510",
    "end": "2982960"
  },
  {
    "text": "[INTERPOSING VOICES] AUDIENCE: --getting more\ninformation out of that. Maybe a weak signal\n[INAUDIBLE] sample [INAUDIBLE]",
    "start": "2982960",
    "end": "2990775"
  },
  {
    "text": "the coherence. AUDIENCE: [INAUDIBLE] a couple\nthings things being combined [INAUDIBLE].",
    "start": "2990775",
    "end": "2996400"
  },
  {
    "text": "Make it one up and one down. [INAUDIBLE] TODD GOLUB: So the\nmicroarrays themselves--",
    "start": "2996400",
    "end": "3005309"
  },
  {
    "text": "the precision of these\narrays is not so fantastic. And so you can imagine if\nthere's a subtle signal.",
    "start": "3005310",
    "end": "3010950"
  },
  {
    "text": "On a gene by gene basis,\nit's difficult to detect it.",
    "start": "3010950",
    "end": "3016410"
  },
  {
    "text": "But if you consider the\ncoordinate regulation of a group of genes all in the\nsame direction, as a group,",
    "start": "3016410",
    "end": "3024022"
  },
  {
    "text": "this might be quite striking. And this is shown right here,\nwhich is really quite amazing when you think about it.",
    "start": "3024022",
    "end": "3030070"
  },
  {
    "text": "So here, look at\nthe mean expression level of all the\ndiabetic patients versus all the normal patients.",
    "start": "3030070",
    "end": "3036990"
  },
  {
    "text": "All the genes on the\narray are shown in gray. And so you would expect\nthere are no outliers.",
    "start": "3036990",
    "end": "3042930"
  },
  {
    "text": "There's nothing really\nway off the diagonal. If they were,\nthose would show up as single genes that were\ndifferentially expressed.",
    "start": "3042930",
    "end": "3052559"
  },
  {
    "text": "Of course, you could\nhave one massive outlier that could screw you up\nwith looking at the means. But still, you get my point.",
    "start": "3052560",
    "end": "3058260"
  },
  {
    "text": "And here are these\noxidative phosphorylation-- the gene set that was defined\nby those genes that are involved",
    "start": "3058260",
    "end": "3065520"
  },
  {
    "text": "in oxidative phosphorylation. And you can see that, with\nonly a few exceptions, they're all lined up\njust below the diagonal.",
    "start": "3065520",
    "end": "3073140"
  },
  {
    "text": "Their change in gene\nexpression is only about 20%",
    "start": "3073140",
    "end": "3079710"
  },
  {
    "text": "compared to normal, but it's\nall in the same direction. So 20% change in this number\nof genes is quite significant.",
    "start": "3079710",
    "end": "3092040"
  },
  {
    "text": "AUDIENCE: Are you getting that? Let me try to-- because it's an incredibly\nimportant point.",
    "start": "3092040",
    "end": "3098490"
  },
  {
    "text": "The chance-- if you look\nat any given dot of thing, what does it means to be 1--",
    "start": "3098490",
    "end": "3104400"
  },
  {
    "text": "near the diagonal,\none side or the other. I'm not going to make\n[INAUDIBLE] story. [INAUDIBLE] about.",
    "start": "3104400",
    "end": "3109773"
  },
  {
    "text": "It's going to be a quick one-- the fact that it's on\none side or the other. And then, just by\ndumb luck, they're",
    "start": "3109773",
    "end": "3116069"
  },
  {
    "text": "all on one side of the diagonal\nif they're put diagonal. That's going to be\nincredibly unlikely.",
    "start": "3116070",
    "end": "3123089"
  },
  {
    "text": "And so each individual gene\nis one side of the diagonal.",
    "start": "3123090",
    "end": "3128820"
  },
  {
    "text": "The fact that all genes that\nwe have pre-assigned beforehand of the other type--\nin this case,",
    "start": "3128820",
    "end": "3134592"
  },
  {
    "text": "[INAUDIBLE] phosphorylation--\nthat will end up on one side of diagonal-- that's hugely unlikely,\nthe fact that you can just,",
    "start": "3134593",
    "end": "3140550"
  },
  {
    "text": "by some luck, put them all\non one side of the diagonal. AUDIENCE: So it's less tied\nto the enrichment [INAUDIBLE]",
    "start": "3140550",
    "end": "3146460"
  },
  {
    "text": "the probability that you\ndefine [INAUDIBLE] that, given",
    "start": "3146460",
    "end": "3152130"
  },
  {
    "text": "that you've said these\nare genes that should be related to some [INAUDIBLE]. AUDIENCE: Yes.",
    "start": "3152130",
    "end": "3157827"
  },
  {
    "text": "AUDIENCE: That makes sense. TODD GOLUB: That's right. AUDIENCE: [INAUDIBLE] together,\nthe classes can be formed. TODD GOLUB: That's right. Because if you look-- if you\ntake this point in isolation,",
    "start": "3157827",
    "end": "3167599"
  },
  {
    "text": "there's no way that that's\ngoing to be significant because it's right\nin the middle--",
    "start": "3167600",
    "end": "3174559"
  },
  {
    "text": "in this thing. So this is an\neye-opening experiment,",
    "start": "3174560",
    "end": "3179599"
  },
  {
    "text": "and it's causing us to\ngo back and reanalyze, using this methodology called\ngene set enrichment analysis,",
    "start": "3179600",
    "end": "3186200"
  },
  {
    "text": "some old data sets. Let me give you a\ncouple of other examples of unpublished examples that\nin a slightly different--",
    "start": "3186200",
    "end": "3192740"
  },
  {
    "text": "use it in a slightly\ndifferent way. So I told you about our\nmedulloblastoma outcome prediction experiments before.",
    "start": "3192740",
    "end": "3198950"
  },
  {
    "text": "And around the same time,\nthere was a paper published",
    "start": "3198950",
    "end": "3204619"
  },
  {
    "text": "that looked at the same\nquestion, essentially. Non-metastatic versus metastatic\nmedulloblastoma-- different",
    "start": "3204620",
    "end": "3212660"
  },
  {
    "text": "patients, different arrays,\ndifferent groups, whatever. They made a classifier that\nwas centered around the PDGF",
    "start": "3212660",
    "end": "3219800"
  },
  {
    "text": "receptor alpha gene-- was a predictor\nand also a number",
    "start": "3219800",
    "end": "3224930"
  },
  {
    "text": "of the downstream players\nof PDGF receptor alpha. And so we asked, are any o--",
    "start": "3224930",
    "end": "3233150"
  },
  {
    "text": "when we look at our\nclassifier of outcome, which I showed you is pretty decent,\nwhere's the PDGF receptor",
    "start": "3233150",
    "end": "3240650"
  },
  {
    "text": "alpha pathway on there? And neither PDGF receptor\nalpha or the genes",
    "start": "3240650",
    "end": "3248300"
  },
  {
    "text": "in that pathway were among\nthe top predictors-- top 50 genes in our\ndata set, one which",
    "start": "3248300",
    "end": "3255290"
  },
  {
    "text": "I think would lead 1 to believe\nthat one or both of those data sets is wrong or the models\nderived from them are wrong.",
    "start": "3255290",
    "end": "3264140"
  },
  {
    "text": "But if you take this PDGF\nreceptor alpha-related genes",
    "start": "3264140",
    "end": "3272269"
  },
  {
    "text": "as a gene set and\nask, is it enriched in our data set using this\nmethodology shown schematically",
    "start": "3272270",
    "end": "3278809"
  },
  {
    "text": "here, it's enriched. This list is 12,000\ngenes long or so.",
    "start": "3278810",
    "end": "3287220"
  },
  {
    "text": "So you can see they're not all\nstacked up, like 1 through 50, but they're non-randomly\ndistributed,",
    "start": "3287220",
    "end": "3292590"
  },
  {
    "text": "which we take to mean that,\nactually, the two data sets are consistent.",
    "start": "3292590",
    "end": "3297720"
  },
  {
    "text": "If you had data sets\nof infinite size, then you'd start\nto see convergence of the markers being overlapping\nat the very top of the list.",
    "start": "3297720",
    "end": "3307550"
  },
  {
    "text": "But with these smaller data sets\nand the clinical variability--",
    "start": "3307550",
    "end": "3312597"
  },
  {
    "text": "AUDIENCE: This\nputs some formalism around what [INAUDIBLE]\nwas waving his hands and yelling about.",
    "start": "3312597",
    "end": "3319040"
  },
  {
    "text": "For five years,\npeople said, well, this microarray [INAUDIBLE]. You can't tell the\ndifference between them. TODD GOLUB: Yeah. AUDIENCE: This is the pattern.",
    "start": "3319040",
    "end": "3325560"
  },
  {
    "text": "It's the overall pattern. This is a much more formal way-- a pattern that's released\nto pick [INAUDIBLE]..",
    "start": "3325560",
    "end": "3331243"
  },
  {
    "text": "TODD GOLUB: So here's another\nexample of that thing. It's also unpublished. So we looked at lung cancer--",
    "start": "3331243",
    "end": "3340370"
  },
  {
    "text": "human adenocarcinoma in the\nlung and identify some-- we just drew the line at 50\nbecause it's a nice number--",
    "start": "3340370",
    "end": "3348500"
  },
  {
    "text": "predictors of outcome in the\nBoston lung cancer patients.",
    "start": "3348500",
    "end": "3353750"
  },
  {
    "text": "University of Michigan\ndid the same experiment, published around the same time. Overlap in gene of these two--",
    "start": "3353750",
    "end": "3360710"
  },
  {
    "text": "listed 50 genes-- zero-- concerning.",
    "start": "3360710",
    "end": "3365869"
  },
  {
    "text": "But if you look in the space\nof gene set space and you ask, what gene sets are\nenriched in one data set?",
    "start": "3365870",
    "end": "3373400"
  },
  {
    "text": "What gene sets-- which you can\nthink of loosely as pathways. They're not really\npathways, but it's",
    "start": "3373400",
    "end": "3378770"
  },
  {
    "text": "reasonable think of\nthem for this purpose. There's really quite significant\noverlap in gene set space.",
    "start": "3378770",
    "end": "3386279"
  },
  {
    "text": "So I think what this is saying\nis that Botstein is right, that there is more biologic\ncoherence in these data sets.",
    "start": "3386280",
    "end": "3394467"
  },
  {
    "text": "It's just we haven't\nbeen smart enough to really know how to see it. AUDIENCE: How did you\nchoose your gene set?",
    "start": "3394467",
    "end": "3400359"
  },
  {
    "text": "[INAUDIBLE] What do you use-- [INAUDIBLE] function\nor is it a pathway? Or how do you\nactually [INAUDIBLE]??",
    "start": "3400360",
    "end": "3407940"
  },
  {
    "text": "TODD GOLUB: We now have about\n450 or so such gene sets-- some of which are\ngood, some of which",
    "start": "3407940",
    "end": "3414150"
  },
  {
    "text": "aren't particularly useful. They include some go annotation. I don't think those\nare particularly",
    "start": "3414150",
    "end": "3420270"
  },
  {
    "text": "useful because the\ngranularity isn't fine enough. I think, in the end, the most\nuseful types of gene sets",
    "start": "3420270",
    "end": "3427290"
  },
  {
    "text": "are going to be those that\nare experimentally derived. But this is a mixture of those,\nand we're not yet at the point",
    "start": "3427290",
    "end": "3434160"
  },
  {
    "text": "where we even started try\nto understand-- of these 35 enriched sets of\ngenes, what are they",
    "start": "3434160",
    "end": "3440849"
  },
  {
    "text": "and what's the biological story? AUDIENCE: You threw at it on\nthe order of 60 gene sets?",
    "start": "3440850",
    "end": "3446550"
  },
  {
    "text": "TODD GOLUB: No. AUDIENCE: No? TODD GOLUB: No. We threw at it 400-and-something\ngene sets and asked,",
    "start": "3446550",
    "end": "3453869"
  },
  {
    "text": "how many of those are enriched\nin the Boston data set? And the answer is 35 plus 18.",
    "start": "3453870",
    "end": "3459420"
  },
  {
    "text": "And 35 plus 12\nwere enriched here. And so the majority of\nthe sets enriched in one",
    "start": "3459420",
    "end": "3467340"
  },
  {
    "text": "were also enriched in the other. AUDIENCE: That's helpful. AUDIENCE: Are those\ncancer-specific or just biological? TODD GOLUB: No, they're\nnot cancer specific.",
    "start": "3467340",
    "end": "3474510"
  },
  {
    "text": "AUDIENCE: And those\ngene sets are manually annotated by their group,\nor is the [INAUDIBLE]??",
    "start": "3474510",
    "end": "3483859"
  },
  {
    "text": "TODD GOLUB: There a\ncombination, as I said. Some are these\n[INAUDIBLE] pathways that are so-so annotation.",
    "start": "3483860",
    "end": "3490700"
  },
  {
    "text": "Some are entirely\ncomputationally derived. That is, they're the nearest\nneighbor genes of a given index",
    "start": "3490700",
    "end": "3499400"
  },
  {
    "text": "gene in a data set. They are various things.",
    "start": "3499400",
    "end": "3506840"
  },
  {
    "text": "And what the definitive\ncollection of gene sets would actually look like\nisn't obvious to me.",
    "start": "3506840",
    "end": "3515403"
  },
  {
    "text": "AUDIENCE: [INAUDIBLE] learn\nmore and more about mechanism. TODD GOLUB: That's right. ",
    "start": "3515403",
    "end": "3522140"
  },
  {
    "text": "On the one hand, I think\nit will be useful to just not fret about it too much\nand worry about exactly",
    "start": "3522140",
    "end": "3530660"
  },
  {
    "text": "how to define these things. Just get them in there. The nice thing about\nthis GSCA methodology",
    "start": "3530660",
    "end": "3536210"
  },
  {
    "text": "that I didn't really\ngo through in detail is that it's forgiving-- how you calculate these\nenrichment scores is forgiving",
    "start": "3536210",
    "end": "3543980"
  },
  {
    "text": "of the definition\nof the gene sets because you're looking\nfor enriched-- non-random enrichment of the gene.",
    "start": "3543980",
    "end": "3549770"
  },
  {
    "text": "Set so the fact that a third\nor a 1/2 of the gene set may actually be\ninappropriately there",
    "start": "3549770",
    "end": "3556248"
  },
  {
    "text": "doesn't make any difference\nbecause there's still enough that significantly\nenriched to detect it.",
    "start": "3556248",
    "end": "3561610"
  },
  {
    "text": "AUDIENCE: You also [INAUDIBLE]?  TODD GOLUB: You can. We didn't happen to do\nit here, but you can.",
    "start": "3561610",
    "end": "3568970"
  },
  {
    "text": "Again, like any of\nthese other things, there are going to be a\nnumber of different metrics that you could apply to\nmeasure significant enrichment.",
    "start": "3568970",
    "end": "3577849"
  },
  {
    "text": "The most important thing\nis just to make sure that you correct for the\npossibility of whatever metric",
    "start": "3577850",
    "end": "3584300"
  },
  {
    "text": "you use-- that you're detecting\nsomething beyond what you'd expect by chance.",
    "start": "3584300",
    "end": "3590580"
  },
  {
    "text": "AUDIENCE: So I have two\nquestions about [INAUDIBLE]..",
    "start": "3590580",
    "end": "3595880"
  },
  {
    "text": "One would be-- so I'm assuming\nthat you can also detect--",
    "start": "3595880",
    "end": "3602750"
  },
  {
    "text": "you have a [INAUDIBLE] of\na particular gene, which you haven't mentioned so far.",
    "start": "3602750",
    "end": "3608590"
  },
  {
    "text": "So is that\n[INAUDIBLE] an example of an actual [INAUDIBLE].",
    "start": "3608590",
    "end": "3614650"
  },
  {
    "text": "Is that something you\nwould find by going back to your healthy\nsamples and comparing--",
    "start": "3614650",
    "end": "3620380"
  },
  {
    "text": "looking for enrichment\nrelative to your disease? AUDIENCE: A positive score?",
    "start": "3620380",
    "end": "3626353"
  },
  {
    "text": "TODD GOLUB: So actually,\nthe way you calculate this is the metric\ndoesn't specifically look",
    "start": "3626353",
    "end": "3632268"
  },
  {
    "text": "for enrichment towards the top. It looks for a\nnon-random distribution. ",
    "start": "3632268",
    "end": "3638589"
  },
  {
    "text": "You would find depletion. What you could also\nfind-- which I think is-- this score will\ncapture and is not",
    "start": "3638590",
    "end": "3645579"
  },
  {
    "text": "desirable-- would\nbe something that's concentrated in the middle,\nwhich is very uninteresting.",
    "start": "3645580",
    "end": "3651910"
  },
  {
    "text": "So there are some false\npositives in there. AUDIENCE: That may not\nactually be so interesting--",
    "start": "3651910",
    "end": "3658120"
  },
  {
    "text": "for example, in\nT-cell activation, you get normal [INAUDIBLE].",
    "start": "3658120",
    "end": "3664570"
  },
  {
    "text": "You get upregulation\nof certain proteins and you get\ndownregulation of others. And so what I haven't heard\nyet is how you account",
    "start": "3664570",
    "end": "3673450"
  },
  {
    "text": "for, perhaps, enrichment of\npart of your genes [INAUDIBLE] increasing another with that--",
    "start": "3673450",
    "end": "3679670"
  },
  {
    "text": "TODD GOLUB: So there\nis another version of this that tries\nto dissect the gene sets into those components\nthat move coherently",
    "start": "3679670",
    "end": "3685842"
  },
  {
    "text": "in one direction\nversus the other, because you're absolutely right. AUDIENCE: [INAUDIBLE] TODD GOLUB: Yeah. If, for example, you take a--",
    "start": "3685843",
    "end": "3693820"
  },
  {
    "text": "use GO annotation or something\nlike that, or some pathway, if half the genes\nin the pathway go up",
    "start": "3693820",
    "end": "3700030"
  },
  {
    "text": "and half the genes go down, that\ncould look like no enrichment",
    "start": "3700030",
    "end": "3705040"
  },
  {
    "text": "at all, whereas, if you\nseparate those somehow, you could see it. ",
    "start": "3705040",
    "end": "3713377"
  },
  {
    "text": "How are we doing for time? AUDIENCE: Well, you've\ngot 20 minutes-- 18 minutes. TODD GOLUB: OK. ",
    "start": "3713377",
    "end": "3720010"
  },
  {
    "text": "So let me push this to-- not classification but\nsome newer directions",
    "start": "3720010",
    "end": "3726155"
  },
  {
    "text": "that we're thinking\nabout-- how can you use these signatures\nfor useful things,",
    "start": "3726155",
    "end": "3732460"
  },
  {
    "text": "particularly to think\nabout something that's closer to drug discovery. So this is the way\nthe usual discovery",
    "start": "3732460",
    "end": "3741920"
  },
  {
    "text": "pipeline would look like. You have some disease\nprocess or biological process you care about. You do some microarray\nexperiments.",
    "start": "3741920",
    "end": "3749240"
  },
  {
    "text": "And then a miracle's is supposed\nto occur whereby you develop sufficient molecular\nunderstanding of what",
    "start": "3749240",
    "end": "3756140"
  },
  {
    "text": "the data are telling you, that\nyou can identify the smoking",
    "start": "3756140",
    "end": "3761930"
  },
  {
    "text": "gun target. And then you partner with\na drug company and say, screen for a small\nmolecule that inhibits",
    "start": "3761930",
    "end": "3768680"
  },
  {
    "text": "this critical\ntherapeutic target. The problem is that this\npart is really tough.",
    "start": "3768680",
    "end": "3774210"
  },
  {
    "text": "And so what we've\nbeen thinking about is, well, could you bypass\nthe understanding part,",
    "start": "3774210",
    "end": "3779690"
  },
  {
    "text": "at least initially,\nwhereby you screen for small molecules\nbased on their ability",
    "start": "3779690",
    "end": "3785930"
  },
  {
    "text": "simply to perturb a\nsignature of interest. And then, once you\nhave those in hand,",
    "start": "3785930",
    "end": "3791180"
  },
  {
    "text": "you could use them to\nfurther dissect the biology or, if you're lucky, think\nabout them like drugs.",
    "start": "3791180",
    "end": "3797510"
  },
  {
    "text": "And so the proof-of-concept\nexperiment is shown here,",
    "start": "3797510",
    "end": "3803280"
  },
  {
    "text": "where-- here are two biological\nstates, for example-- a leukemia cell, which\nis undifferentiated,",
    "start": "3803280",
    "end": "3809930"
  },
  {
    "text": "and a normal blood cell,\nwhich is fully mature and is differentiated\nalong the myeloid pathway--",
    "start": "3809930",
    "end": "3817940"
  },
  {
    "text": "a peripheral blood neutrophil. It's not known what the critical\ntargets are of this pathway.",
    "start": "3817940",
    "end": "3825450"
  },
  {
    "text": "So it's hard to do\na small molecule screen to induce this\nprocess, which would be nice, if you could simply induce\nyour leukemia cells to turn",
    "start": "3825450",
    "end": "3833670"
  },
  {
    "text": "into normal cells. So the question\nis, could we define a signature of this state,\na signature of this state,",
    "start": "3833670",
    "end": "3840260"
  },
  {
    "text": "and then screen for compounds\nthat trigger the signature? So the details\ndon't matter here,",
    "start": "3840260",
    "end": "3846320"
  },
  {
    "text": "but the concept is,\ndefine signatures of the two states of interest.",
    "start": "3846320",
    "end": "3852570"
  },
  {
    "text": "So we call this thing GEHTS,\nfor gene expression based high throughput screening.",
    "start": "3852570",
    "end": "3858890"
  },
  {
    "text": "Define the signatures--\nnow standards-- what we've been talking\nabout-- our microarrays,",
    "start": "3858890",
    "end": "3864800"
  },
  {
    "text": "where the experiment would be-- treat cells with various\ndifferent chemical compounds",
    "start": "3864800",
    "end": "3871039"
  },
  {
    "text": "and ask whether any\nof those compounds trigger the signature\nof interest.",
    "start": "3871040",
    "end": "3876500"
  },
  {
    "text": "And to make this\nfeasible, we simplify these complex signatures\ninto a handful of genes",
    "start": "3876500",
    "end": "3883460"
  },
  {
    "text": "that you can measure\nby multiplexed PCR. AUDIENCE: I read the paper. Was just purely a cost\nissue as opposed to",
    "start": "3883460",
    "end": "3891319"
  },
  {
    "text": "going directly to\nthe microarrays? TODD GOLUB: It's a cost\nand throughput issue. Yeah, so if you wanted to-- AUDIENCE: We're good.",
    "start": "3891320",
    "end": "3896905"
  },
  {
    "text": "[INAUDIBLE]  TODD GOLUB: If you wanted\nto screen tens of thousands",
    "start": "3896905",
    "end": "3902390"
  },
  {
    "text": "of compounds, not\nreally feasible if it costs you $500 a pop\nin the throughput issue.",
    "start": "3902390",
    "end": "3911270"
  },
  {
    "text": "So yeah, it's a\npractical matter here. This part doesn't matter. Suffice it to say\nthere's a method for how",
    "start": "3911270",
    "end": "3919430"
  },
  {
    "text": "to measure a simplified\nsignature in high throughput. ",
    "start": "3919430",
    "end": "3926069"
  },
  {
    "text": "So we screened a couple\nthousand compounds and asked,",
    "start": "3926070",
    "end": "3932160"
  },
  {
    "text": "do any of them trigger this\nlittle mini gene signature? And some of them did.",
    "start": "3932160",
    "end": "3937370"
  },
  {
    "text": "Details don't matter. But then the question should\nbe, well, maybe these things",
    "start": "3937370",
    "end": "3942950"
  },
  {
    "text": "just trigger these\nfive genes that are-- I'm sorry, these compounds\ntrigger the five genes",
    "start": "3942950",
    "end": "3949010"
  },
  {
    "text": "but actually don't do anything. So one way that you could\nsort out whether they actually do anything biologically is\nto now step back and look",
    "start": "3949010",
    "end": "3956180"
  },
  {
    "text": "across the whole genome\nagain, take cells, treat them with these candidate\ncompounds, and ask,",
    "start": "3956180",
    "end": "3961580"
  },
  {
    "text": "did you actually recapitulate\nthe overall molecular program, not just of these five genes\nbut of the whole thing--",
    "start": "3961580",
    "end": "3968840"
  },
  {
    "text": "of the whole molecular program? So if you turn back\nto genome-wide arrays,",
    "start": "3968840",
    "end": "3974460"
  },
  {
    "text": "you can see that a\nnumber of these compounds recapitulated the molecular\nprogram of differentiation.",
    "start": "3974460",
    "end": "3982369"
  },
  {
    "text": "Does that make sense? So you use the simplified\nhigh throughput assay just as",
    "start": "3982370",
    "end": "3988580"
  },
  {
    "text": "a readout of whether you've\ntriggered the signature or not. And then, with those\ncandidates in hand,",
    "start": "3988580",
    "end": "3994520"
  },
  {
    "text": "you go back and\ninterrogate them. AUDIENCE: Does\neverybody follow that?",
    "start": "3994520",
    "end": "3999800"
  },
  {
    "text": "TODD GOLUB: So the genes in\nthis little signature itself-- AUDIENCE: We don't if they're\nactually doing anything",
    "start": "3999800",
    "end": "4005410"
  },
  {
    "text": "to the rest of the cell. TODD GOLUB: I'm pretty\nconfident they don't, actually. But it's irrelevant.",
    "start": "4005410",
    "end": "4010610"
  },
  {
    "text": "So you define these\nsignatures not based on their being important\nor somebody thinks, oh, that's a good target, and\nthat's important for leukemia",
    "start": "4010610",
    "end": "4018338"
  },
  {
    "text": "or differentiation or whatever. It simply-- AUDIENCE: Represents the class. TODD GOLUB: It\nrepresents the class. All you care about.",
    "start": "4018338",
    "end": "4023930"
  },
  {
    "text": "And that you can\nmeasure it well. So sometimes you find\na good candidate marker that, for some reason,\nit doesn't behave nicely",
    "start": "4023930",
    "end": "4032079"
  },
  {
    "text": "in this assay so\nyou chuck it out and replace it with\nsomething else. ",
    "start": "4032080",
    "end": "4039799"
  },
  {
    "text": "So here's just an example to say\nthat then, as you might expect,",
    "start": "4039800",
    "end": "4045160"
  },
  {
    "text": "when you treat leukemia cells\nwith these candidate compounds, discovered solely based on\ntheir gene expression changes,",
    "start": "4045160",
    "end": "4052030"
  },
  {
    "text": "they do the thing-- the cells\ndo the things that maturing leukemia cells should do,\nlike-- they become phagocytic.",
    "start": "4052030",
    "end": "4058089"
  },
  {
    "text": "They start engulfing-- AUDIENCE: [INAUDIBLE]\nmuch more differentiated like in their behavior. TODD GOLUB: Yeah, so\nit's a promising idea.",
    "start": "4058090",
    "end": "4066580"
  },
  {
    "text": "This is one unpublished\nexample that says, well, it is known that blood cell\ndifferentiation is largely",
    "start": "4066580",
    "end": "4078670"
  },
  {
    "text": "governed at the\ntranscriptional level. So maybe that's\nwhy you can define these transcriptional signatures\nof the differentiation process",
    "start": "4078670",
    "end": "4086440"
  },
  {
    "text": "and screen for things. But here's an example of\ndefining a gene expression",
    "start": "4086440",
    "end": "4091630"
  },
  {
    "text": "signature. Again, the signature\nitself is devoid of any real biological meaning,\nother than it reads out,",
    "start": "4091630",
    "end": "4100120"
  },
  {
    "text": "in this case, activation of a\nsignal transduction pathway. So the usual way of thinking\nabout this is, well,",
    "start": "4100120",
    "end": "4106179"
  },
  {
    "text": "if you want to look at signal\ntransduction-- proteins talk to each other, RNA\nhas no place in that.",
    "start": "4106180",
    "end": "4111399"
  },
  {
    "text": "RNA profiling has\nno place in that. But here the idea is, if we\nstimulate a signaling pathway-- in this case, by\nstimulating cells",
    "start": "4111399",
    "end": "4117370"
  },
  {
    "text": "with platelet-derived\ngrowth factor and then capture the\ntranscriptional response",
    "start": "4117370",
    "end": "4123310"
  },
  {
    "text": "at the RNA level, could\nwe use an RNA signature as a readout for PDGF receptor\nactivation and a screen",
    "start": "4123310",
    "end": "4131170"
  },
  {
    "text": "for inhibitors of the\nsignal transduction pathway using RNA as a readout?",
    "start": "4131170",
    "end": "4136989"
  },
  {
    "text": "And here, this is work of\na MIT graduate student-- chemistry graduate student,\nwho pulled out a compound",
    "start": "4136990",
    "end": "4144880"
  },
  {
    "text": "called aurintricarboxylic acid\nas an example, which turns out to be a previously unknown\ninhibitor of the PDGF receptor",
    "start": "4144880",
    "end": "4155770"
  },
  {
    "text": "itself. But it was discovered by looking\ndown here at a signature.",
    "start": "4155770",
    "end": "4160960"
  },
  {
    "text": "So I think this is going\nto be useful for various-- being able to screen for\nthings that you can't otherwise",
    "start": "4160960",
    "end": "4168759"
  },
  {
    "text": "screen for. So this is a chemical\nstructure that is not currently",
    "start": "4168760",
    "end": "4174370"
  },
  {
    "text": "being explored in people\nwho know much more than I do about kinase inhibitors\nbecause no one thought",
    "start": "4174370",
    "end": "4182439"
  },
  {
    "text": "to look at it. And it was discovered simply\nby using as a signature, as a readout.",
    "start": "4182439",
    "end": "4189100"
  },
  {
    "text": "So the last five minutes, let me\npush the signature idea perhaps",
    "start": "4189100",
    "end": "4194680"
  },
  {
    "text": "further than I should. AUDIENCE: But it's\nthe end of the class. TODD GOLUB: But it's\nthe end of the class, and I'm excited about the idea.",
    "start": "4194680",
    "end": "4200350"
  },
  {
    "text": "But it has less\ndata surrounding it. And that's the idea of\nusing these signatures--",
    "start": "4200350",
    "end": "4208960"
  },
  {
    "text": "so you can see, at least in-- my thinking has shifted\nover the past year or so,",
    "start": "4208960",
    "end": "4214420"
  },
  {
    "text": "much away from finding,\noh, what's the needle-- using these microarray\ntypes of experiments",
    "start": "4214420",
    "end": "4220180"
  },
  {
    "text": "to find a needle in\na haystack-- what's the gene that's responsible\nfor something I care about? To thinking about the\npower of these signatures",
    "start": "4220180",
    "end": "4227050"
  },
  {
    "text": "as readouts for various things. So the idea here is to\nuse the signatures--",
    "start": "4227050",
    "end": "4234520"
  },
  {
    "text": "RNA signatures as a vehicle\nfor establishing connectivity",
    "start": "4234520",
    "end": "4241000"
  },
  {
    "text": "between components of the\ngenome and each other,",
    "start": "4241000",
    "end": "4247900"
  },
  {
    "text": "that you manipulate\nthrough perturbation. It's a little bit different than\nrelevance networks, I think,",
    "start": "4247900",
    "end": "4253210"
  },
  {
    "text": "but it's conceptually similar. AUDIENCE: [INAUDIBLE] TODD GOLUB:\nEstablishing connections",
    "start": "4253210",
    "end": "4259150"
  },
  {
    "text": "between drugs and drugs\nand drugs and genes. So the idea would be that,\nif you can define a gene",
    "start": "4259150",
    "end": "4264280"
  },
  {
    "text": "expression signature\nof, let's say-- comprehensively of all drugs--",
    "start": "4264280",
    "end": "4273520"
  },
  {
    "text": "there are only about\n2,000 FDA-approved drugs. It's actually amazing\nthat that's just",
    "start": "4273520",
    "end": "4278770"
  },
  {
    "text": "not publicly available\ninformation, what happens to cells\nwhen you treat them with drugs we give to patients.",
    "start": "4278770",
    "end": "4285880"
  },
  {
    "text": "If you had that\nand, for example, you had a signature that was\na result of ablating each gene",
    "start": "4285880",
    "end": "4293139"
  },
  {
    "text": "in the genome sequentially--\nonly 26,000 genes in the genome, and there are now\nreagents coming online with RNA",
    "start": "4293140",
    "end": "4299800"
  },
  {
    "text": "interference where you can\nactually do that experiment-- then you'd have a systematic\nmatrix of perturbations",
    "start": "4299800",
    "end": "4308110"
  },
  {
    "text": "whereby you use these\ngene expression signatures",
    "start": "4308110",
    "end": "4313449"
  },
  {
    "text": "as the universal bio assay\nto connect genes with genes,",
    "start": "4313450",
    "end": "4321040"
  },
  {
    "text": "genes with drugs,\nand drugs with drugs. Does that make sense? Do you have a question?",
    "start": "4321040",
    "end": "4326690"
  },
  {
    "text": "AUDIENCE: [INAUDIBLE] ",
    "start": "4326690",
    "end": "4349310"
  },
  {
    "text": "How do we prevent from\n[INAUDIBLE] to the [INAUDIBLE] cancer cells [INAUDIBLE]\ncancer cells.",
    "start": "4349310",
    "end": "4358100"
  },
  {
    "text": "But because of [INAUDIBLE]-- because of [INAUDIBLE]. ",
    "start": "4358100",
    "end": "4368460"
  },
  {
    "text": "TODD GOLUB: Well,\nwe're arguing that-- don't bother doing\nthis in lower organisms",
    "start": "4368460",
    "end": "4373950"
  },
  {
    "text": "because you can do the\nexperiment in human cells. So we're going to do\nit in human cells. And I would say--\nthe idea, again,",
    "start": "4373950",
    "end": "4380130"
  },
  {
    "text": "for establishing these\nconnections is not to be able to-- AUDIENCE: Be perfect. TODD GOLUB: I think\npeople who think",
    "start": "4380130",
    "end": "4386370"
  },
  {
    "text": "that you can create\na wiring diagram and reverse engineer a\ncell are out of their minds",
    "start": "4386370",
    "end": "4392700"
  },
  {
    "text": "based on these data. It's just not feasible. So the question\nis, can you find--",
    "start": "4392700",
    "end": "4399090"
  },
  {
    "text": "can you find, for example,\nenrichment in the same GSCA kind of thinking?",
    "start": "4399090",
    "end": "4405119"
  },
  {
    "text": "Can you find enrichment of\none signature in another, thereby establishing\nconnectivity, in which case",
    "start": "4405120",
    "end": "4412050"
  },
  {
    "text": "yes, you'll get some of it wrong\nbecause the context isn't right or the species\nmapping isn't right. But will you be able to\nsee enough connections",
    "start": "4412050",
    "end": "4419530"
  },
  {
    "text": "to establish connectivity?  AUDIENCE: [INAUDIBLE]",
    "start": "4419530",
    "end": "4426889"
  },
  {
    "text": " TODD GOLUB: Yep. AUDIENCE: Sure. TODD GOLUB: Yep, certainly some. We're finding, actually-- I'll\ngive you a couple of examples",
    "start": "4426890",
    "end": "4433110"
  },
  {
    "text": "that-- while that is certain to be--\nthat context-dependence is certain to be the case--",
    "start": "4433110",
    "end": "4438350"
  },
  {
    "text": "AUDIENCE: There's\nlots that's shared. TODD GOLUB: There's\nlots that shared. And so, when we first started\ntalking about this project,",
    "start": "4438350",
    "end": "4444030"
  },
  {
    "text": "there were a lot of objections\nto the idea-- oh, still are, that, oh, what if you\ndon't choose the right cell",
    "start": "4444030",
    "end": "4450980"
  },
  {
    "text": "line to do this in? Ideally, you would do it in\nlike 100 different cell types. But then it gets then it gets\nto be a serious experiment.",
    "start": "4450980",
    "end": "4457550"
  },
  {
    "text": "Even in one cell line,\nit's a huge experiment. AUDIENCE: I think\nI told this group",
    "start": "4457550",
    "end": "4462890"
  },
  {
    "text": "that I've seen the same thing\nin [INAUDIBLE] relationships. Many, many cell types that\npeople wouldn't think they",
    "start": "4462890",
    "end": "4469040"
  },
  {
    "text": "would be there. They're just there. TODD GOLUB: Yeah, exactly. So let me give a couple\nexamples and then we'll end.",
    "start": "4469040",
    "end": "4478070"
  },
  {
    "text": "And it also-- again, comes back\nto this idea of enrichment, looking for enrichment using a\nKolmogorov-Smirnov enrichment",
    "start": "4478070",
    "end": "4485120"
  },
  {
    "text": "test. So here is an experiment\nthat was published",
    "start": "4485120",
    "end": "4490130"
  },
  {
    "text": "not by us, but by a group at\nAbbott Laboratories, where they are interested in this\nclass of drugs called",
    "start": "4490130",
    "end": "4495619"
  },
  {
    "text": "histone deacetylase inhibitors. They took-- what is it? Five of these things,\ntreated cells,",
    "start": "4495620",
    "end": "4503360"
  },
  {
    "text": "took a common set of\ngenes that were regulated, defined a signature of 22 genes.",
    "start": "4503360",
    "end": "4509540"
  },
  {
    "text": "It's a gene set. It's the HDAC\ninhibitor gene set. We took breast cancer cells--",
    "start": "4509540",
    "end": "4517130"
  },
  {
    "text": "not the cell type they used-- and treated them with a\nbunch of different drugs, including one,\nvalproic acid, which",
    "start": "4517130",
    "end": "4523969"
  },
  {
    "text": "is actually used to treat\nseizures, as it turns out. It was later discovered\nvalproic acid actually",
    "start": "4523970",
    "end": "4529820"
  },
  {
    "text": "has histone deacetylase\ninhibitory activity. It's weak, but it's there.",
    "start": "4529820",
    "end": "4535070"
  },
  {
    "text": "And we ask, can we see\nenrichment of this signature in any of those compounds?",
    "start": "4535070",
    "end": "4542719"
  },
  {
    "text": "And the answer is, yes. So Trichostatin A was\nactually-- where is it? Here's the top one--\nwas one of the drugs",
    "start": "4542720",
    "end": "4548990"
  },
  {
    "text": "that they used to\ndefine the signature. So we recovered it-- not surprisingly. But it's a little bit\ncheating because it",
    "start": "4548990",
    "end": "4555949"
  },
  {
    "text": "wasn't a new example. But here, you see sodium\nvalproate, third and fourth ranked on the\nlist, which was not",
    "start": "4555950",
    "end": "4562429"
  },
  {
    "text": "used to define the\nsignature but simply based on the signature connectivity.",
    "start": "4562430",
    "end": "4568070"
  },
  {
    "text": "Had we not known it, we\ncould have rediscovered that-- we could have discovered\nthat sodium valproate was",
    "start": "4568070",
    "end": "4575000"
  },
  {
    "text": "an extract inhibitor because\nof this connectivity. You can also see here-- Trichostatin A-- so the\nsignature is defined--",
    "start": "4575000",
    "end": "4581750"
  },
  {
    "text": "I can't even remember--\nin one cell type. And we see it triggering the\nsignature-- the HDAC inhibitor",
    "start": "4581750",
    "end": "4588350"
  },
  {
    "text": "signature in breast cancer\ncells and in leukemia cells. So it's robust\n[INAUDIBLE] context.",
    "start": "4588350",
    "end": "4595790"
  },
  {
    "text": "Interestingly, we also ran\nour little connectivity-- mini",
    "start": "4595790",
    "end": "4601430"
  },
  {
    "text": "connectivity map across the\noxidative phosphorylation signature that we define. AUDIENCE: Does the [INAUDIBLE]\nprotease cause hypoglycemia?",
    "start": "4601430",
    "end": "4608270"
  },
  {
    "text": "TODD GOLUB: It does. We didn't know that. We thought we discovered\nsomething new. AUDIENCE: It's the\nwrong specialty.",
    "start": "4608270",
    "end": "4613370"
  },
  {
    "text": "TODD GOLUB: In the\nwrong specialty. Yeah, it was reported\nabout 20 years ago that valproate causes\nhyperglycemia and modulates",
    "start": "4613370",
    "end": "4620510"
  },
  {
    "text": "oxidative phosphorylation-- separable activities, separable\nfrom the anti seizure activity,",
    "start": "4620510",
    "end": "4627260"
  },
  {
    "text": "separable from the HDAC\ninhibitor activity, and they trigger\nseparate gene sets.",
    "start": "4627260",
    "end": "4633240"
  },
  {
    "text": "So one last example-- a signature defined of\na drug called rapamycin,",
    "start": "4633240",
    "end": "4641239"
  },
  {
    "text": "which sits in this pathway\nsimplified here of PI3 kinase AKT, and a protein called mTOR.",
    "start": "4641240",
    "end": "4651920"
  },
  {
    "text": "And it turns out\nthat, if you define the signature of\nrapamycin treatment",
    "start": "4651920",
    "end": "4659280"
  },
  {
    "text": "here, its defining T-cells\npublished by David Sabatini,",
    "start": "4659280",
    "end": "4665110"
  },
  {
    "text": "and apply that signature\nto our connectivity matrix, you see that rapamycin itself is\nrecovered in two different cell",
    "start": "4665110",
    "end": "4673030"
  },
  {
    "text": "types. But also, this thing-- LY294002-- we didn't know\nwhat that was initially.",
    "start": "4673030",
    "end": "4678490"
  },
  {
    "text": "But then you look it up. It's actually an\ninhibitor of PI3 kinase, which is upstream of mTOR.",
    "start": "4678490",
    "end": "4685060"
  },
  {
    "text": "So it puts, in the\nsame pathway, two drugs that act together and\ntrigger the same signature.",
    "start": "4685060",
    "end": "4691690"
  },
  {
    "text": "| again, I don't\nthink it's going to be possible in the near\nterm to actually reconstruct",
    "start": "4691690",
    "end": "4697270"
  },
  {
    "text": "signal transduction\npathways in their entirety. But to be able to put either\ngenes or drugs together",
    "start": "4697270",
    "end": "4706210"
  },
  {
    "text": "in a pathway not\npreviously known to be in the same\npathway, I think,",
    "start": "4706210",
    "end": "4711400"
  },
  {
    "text": "is going to be possible\nwith this approach. So we're committed\nto figuring out how to launch what would be\na large scale public domain",
    "start": "4711400",
    "end": "4720550"
  },
  {
    "text": "connectivity map project, where\nwe would do these perturbations",
    "start": "4720550",
    "end": "4725708"
  },
  {
    "text": "and put the data in\nthe public domain so that people could\nuse the data to find their own connections.",
    "start": "4725708",
    "end": "4732490"
  },
  {
    "text": "AUDIENCE: [INAUDIBLE]  There is a database\nthat's recording",
    "start": "4732490",
    "end": "4739670"
  },
  {
    "text": "some molecules [INAUDIBLE]. ",
    "start": "4739670",
    "end": "4749040"
  },
  {
    "text": "What will be the major\ndifference between this project and that one? TODD GOLUB: I'm not\nsure I know what--",
    "start": "4749040",
    "end": "4756078"
  },
  {
    "text": "AUDIENCE: I think she's\ntalking about the [INAUDIBLE].. An expression, right? AUDIENCE: Yeah,\nvery expression when",
    "start": "4756078",
    "end": "4762390"
  },
  {
    "text": "conditions on the molecules-- TODD GOLUB: On response\nto the molecules. This is actual response\nto the molecules.",
    "start": "4762390",
    "end": "4769750"
  },
  {
    "text": "So that data set is the\nresting, untreated expression",
    "start": "4769750",
    "end": "4775470"
  },
  {
    "text": "of the cell lines, which\nyou can then correlate with how they respond. This is the acute\nchanges of response,",
    "start": "4775470",
    "end": "4784167"
  },
  {
    "text": "because the nice thing\nabout that experiment is that you only have to\nmeasure each cell line once and then you can correlate\nit with all those things.",
    "start": "4784167",
    "end": "4790417"
  },
  {
    "text": "Here, you actually have to do a\nmicroarray for each different-- AUDIENCE: Condition time point. TODD GOLUB: Yep.",
    "start": "4790417",
    "end": "4796020"
  },
  {
    "text": "OK, so the last slide. Whoops, let's skip that. ",
    "start": "4796020",
    "end": "4802450"
  },
  {
    "text": "There's some future challenges. Just to remember that\nthese prognostic signatures",
    "start": "4802450",
    "end": "4809520"
  },
  {
    "text": "that everyone's developing are\nreally a function of therapy.",
    "start": "4809520",
    "end": "4814941"
  },
  {
    "text": "They're likely only to\nbe useful if you continue to use the same therapy.",
    "start": "4814941",
    "end": "4820140"
  },
  {
    "text": "So in this\nmedulloblastoma example, we can predict things\npretty well as long as we're trying to predict\nresponse to therapy",
    "start": "4820140",
    "end": "4826620"
  },
  {
    "text": "that was given 10 years ago. But the therapy has evolved,\nand it's not certain",
    "start": "4826620",
    "end": "4832680"
  },
  {
    "text": "that our classifier\nwill still hold. This is going to be challenging\nbecause the clinical trials are",
    "start": "4832680",
    "end": "4838620"
  },
  {
    "text": "generally small and underpowered\nto do this kind of thing. Still not clear how, once\nthese signatures are actually",
    "start": "4838620",
    "end": "4846150"
  },
  {
    "text": "vetted and validated,\nwhat form will they take when they actually\ngo to the clinic? Will they be a microarray?",
    "start": "4846150",
    "end": "4852475"
  },
  {
    "text": "Maybe.  I've given you some\nideas about how",
    "start": "4852475",
    "end": "4859930"
  },
  {
    "text": "one might do signature-based\nchemical discovery. But turning a\nchemical into a drug",
    "start": "4859930",
    "end": "4867250"
  },
  {
    "text": "is a big deal and not easy. And so for that reason,\npharmaceutical companies",
    "start": "4867250",
    "end": "4873257"
  },
  {
    "text": "aren't dropping their\ncurrent approach to drug discovery\nin favor of this. And in general, how to integrate\nthese kind of signatures",
    "start": "4873257",
    "end": "4879790"
  },
  {
    "text": "into the drug\ndevelopment process is still something\nto think about. But I still think this\nnotion of using these tools--",
    "start": "4879790",
    "end": "4888440"
  },
  {
    "text": "whatever personalized\nmedicine means-- but to gain more insight\ninto the particulars",
    "start": "4888440",
    "end": "4893560"
  },
  {
    "text": "of a given individual's\ndisease to better match them with an existing\nor new therapeutic",
    "start": "4893560",
    "end": "4900370"
  },
  {
    "text": "is likely to be\nhere to stay even though there aren't a lot of\nexamples of it happening yet.",
    "start": "4900370",
    "end": "4906850"
  },
  {
    "text": "That's all I have.",
    "start": "4906850",
    "end": "4909120"
  }
]